Table of Contents
New Journal of Science
Volume 2014 (2014), Article ID 231418, 36 pages
http://dx.doi.org/10.1155/2014/231418
Review Article

Protein Kinase C (PKC) Isozymes and Cancer

Division of Biopharmaceutics and Pharmacokinetics, Department of Biomedical Engineering, National Cerebral and Cardiovascular Center Research Institute, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan

Received 16 January 2014; Accepted 24 March 2014; Published 4 May 2014

Academic Editor: Eric Hajduch

Copyright © 2014 Jeong-Hun Kang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. F. Steinberg, “Structural basis of protein kinase C isoform function,” Physiological Reviews, vol. 88, no. 4, pp. 1341–1378, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. E. M. Griner and M. G. Kazanietz, “Protein kinase C and other diacylglycerol effectors in cancer,” Nature Reviews Cancer, vol. 7, no. 4, pp. 281–294, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Churchill, G. Budas, A. Vallentin, T. Koyanagi, and D. Mochly-Rosen, “PKC isozymes in chronic cardiac disease: possible therapeutic targets?” Annual Review of Pharmacology and Toxicology, vol. 48, pp. 569–599, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. S. S. Palaniyandi, L. Sun, J. C. B. Ferreira, and D. Mochly-Rosen, “Protein kinase C in heart failure: a therapeutic target?” Cardiovascular Research, vol. 82, no. 2, pp. 229–239, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. R. Lee, W. Duan, and S. Tan, “Protein kinase C isozymes as potential therapeutic targets in immune disorders,” Expert Opinion on Therapeutic Targets, vol. 12, no. 5, pp. 535–552, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. D. H. Boschelli, “Small molecule inhibitors of PKCθ as potential antiinflammatory therapeutics,” Current Topics in Medicinal Chemistry, vol. 9, no. 7, pp. 640–654, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. C. A. Zarate and H. K. Manji, “Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder,” CNS Drugs, vol. 23, no. 7, pp. 569–582, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Pascale, M. Amadio, S. Govoni, and F. Battaini, “The aging brain, a key target for the future: the protein kinase C involvement,” Pharmacological Research, vol. 55, no. 6, pp. 560–569, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. R. V. Farese and M. P. Sajan, “Atypical protein kinase C in cardiometabolic abnormalities,” Current Opinion in Lipidology, vol. 23, no. 3, pp. 175–181, 2012. View at Google Scholar
  10. M. Clarke and P. M. Dodson, “PKC inhibition and diabetic microvascular complications,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 21, no. 4, pp. 573–586, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Das Evcimen and G. L. King, “The role of protein kinase C activation and the vascular complications of diabetes,” Pharmacological Research, vol. 55, no. 6, pp. 498–510, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. H.. Kang, R. Toita, C. W. Kim, and Y. Katayama, “Protein kinase C, (PKC) isozyme-specific substrates and their design,” Biotechnology Advances, vol. 30, no. 6, pp. 1662–1672, 2012. View at Google Scholar
  13. H. J. Mackay and C. J. Twelves, “Targeting the protein kinase C family: are we there yet?” Nature Reviews Cancer, vol. 7, no. 7, pp. 554–562, 2007. View at Google Scholar
  14. R. P. Danis and M. J. Sheetz, “Ruboxistaurin: PKC-β inhibition for complications of diabetes,” Expert Opinion on Pharmacotherapy, vol. 10, no. 17, pp. 2913–2925, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. E. Sobhia, B. K. Grewal, S. P. Ml et al., “Protein kinase C inhibitors: a patent review (2008-2009),” Expert Opinion on Therapeutic Patents, vol. 23, no. 10, pp. 1297–1315, 2013. View at Publisher · View at Google Scholar
  16. M. E. Sobhia, B. K. Grewal, M. L. Paul et al., “Protein kinase C inhibitors: a patent review (2010—present),” Expert Opinion on Therapeutic Patents, vol. 23, no. 11, pp. 1451–1468, 2013. View at Publisher · View at Google Scholar
  17. K. Kielbassa, H.-J. Müller, H. E. Meyer, F. Marks, and M. Gschwendt, “Protein kinase Cδ-specific phosphorylation of the elongation factor eEF- 1α and an eEF-1α peptide at threonine 431,” The Journal of Biological Chemistry, vol. 270, no. 11, pp. 6156–6162, 1995. View at Publisher · View at Google Scholar · View at Scopus
  18. J. H. Kang, D. Asai, S. Yamada et al., “A short peptide is a protein kinase C (PKC) α-specific substrate,” Proteomics, vol. 8, no. 10, pp. 2006–2011, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Kajimoto, S. Sawamura, Y. Tohyama, Y. Mori, and A. C. Newton, “Protein kinase C δ-specific activity reporter reveals agonist-evoked nuclear activity controlled by Src family of kinases,” The Journal of Biological Chemistry, vol. 285, no. 53, pp. 41896–41910, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Serulle, G. Morfini, G. Pigino et al., “1-methyl-4-phenylpyridinium induces synaptic dysfunction through a pathway involving caspase and PKCδ enzymatic activities,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 7, pp. 2437–2441, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. V. O. Rybin, A. Sabri, J. Short, J. C. Braz, J. D. Molkentin, and S. F. Steinberg, “Cross-regulation of novel protein kinase C (PKC) isoform function in cardiomyocytes: role of PKCε in activation loop phosphorylations and PKCδ in hydrophobic motif phosphorylations,” The Journal of Biological Chemistry, vol. 278, no. 16, pp. 14555–14564, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. J. H. Kang, D. Asai, R. Toita, H. Kitazaki, and Y. Katayama, “Plasma protein kinase C (PKC)α as a biomarker for the diagnosis of cancers,” Carcinogenesis, vol. 30, no. 11, pp. 1927–1931, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. H. Kang, Y. Asami, M. Murata et al., “Gold nanoparticle-based colorimetric assay for cancer diagnosis,” Biosensors and Bioelectronics, vol. 25, no. 8, pp. 1869–1874, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. J. H. Kang, J. Oishi, J. Kim et al., “Hepatoma-targeted gene delivery using a tumor cell-specific gene regulation system combined with a human liver cell-specific bionanocapsule,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 6, no. 4, pp. 583–589, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. J. H. Kang, D. Asai, J. Kim et al., “Design of polymeric carriers for cancer-specific gene targeting: utilization of abnormal protein kinase Cα activation in cancer cells,” Journal of the American Chemical Society, vol. 130, no. 45, pp. 14906–14907, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Toita, J. H.. Kang, T. Tomiyama et al., “Gene carrier showing all-or-none response to cancer cell signaling,” Journal of the American Chemical Society, vol. 134, no. 37, pp. 15410–15417, 2012. View at Google Scholar
  27. C.-C. Chen, J. Chang, and W.-C. Chen, “Role of protein kinase C subtypes α and δ in the regulation of bradykinin-stimulated phosphoinositide breakdown in astrocytes,” Molecular Pharmacology, vol. 48, no. 1, pp. 39–47, 1995. View at Google Scholar · View at Scopus
  28. A. Varga, G. Czifra, B. Tállai et al., “Tumor grade-dependent alterations in the protein kinase C isoform pattern in urinary bladder carcinomas,” European Urology, vol. 46, no. 4, pp. 462–465, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Langzam, R. Koren, R. Gal et al., “Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder relation to degree of malignancy,” American Journal of Clinical Pathology, vol. 116, no. 3, pp. 377–385, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Koren, L. Langzam, A. Paz, P. M. Livne, R. Gal, and S. R. Sampson, “Protein kinase C (PKC) isoenzymes immunohistochemistry in lymph node revealing solution-fixed, paraffin-embedded bladder tumors,” Applied Immunohistochemistry and Molecular Morphology, vol. 8, no. 2, pp. 166–171, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Kong, Y. Zhu, D. Liu et al., “Role of protein kinase C-alpha in superficial bladder carcinoma recurrence,” Urology, vol. 65, no. 6, pp. 1228–1232, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. A. V. Smrcka, J. H.. Brown, and G. G. Holz, “Role of phospholipase Cε in physiological phosphoinositide signaling networks,” Cellular Signalling, vol. 24, no. 6, pp. 1333–1343, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Yan, C. Luo, X. Wu, and Q. Zhang, “Involvement of the PLCε/PKCα pathway in human BIU-87 bladder cancer cell proliferation,” Cell Biology International, vol. 35, no. 10, pp. 1031–1036, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Aaltonen and J. Peltonen, “PKCα/β I inhibitor Go6976 induces dephosphorylation of constitutively hyperphosphorylated Rb and G1 arrest in T24 cells,” Anticancer Research, vol. 30, no. 10, pp. 3995–3999, 2010. View at Google Scholar · View at Scopus
  35. J. Koivunen, V. Aaltonen, S. Koskela, P. Lehenkar, M. Laato, and J. Peltonen, “Protein kinase C α/β inhibitor Go6976 promotes formation of cell junctions and inhibits invasion of urinary bladder carcinoma cells,” Cancer Research, vol. 64, no. 16, pp. 5693–5701, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. K. A. Fitzgerald, A. G. Bowie, B. S. Skeffington, and L. A. J. O'Neill, “Ras, protein kinase Cζ, and IκB kinases 1 and 2 are downstream effectors of CD44 during the activation of NF-κB by hyaluronic acid fragments in T-24 carcinoma cells,” Journal of Immunology, vol. 164, no. 4, pp. 2053–2063, 2000. View at Google Scholar · View at Scopus
  37. M. Kim, H. Kwak, J. Lee et al., “17-allylamino-17-demethoxygeldanamycin down-regulates hyaluronic acid-induced glioma invasion by blocking matrix metalloproteinase-9 secretion,” Molecular Cancer Research, vol. 6, no. 11, pp. 1657–1665, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Y. W. Bourguignon, C. C. Spevak, G. Wong, W. Xia, and E. Gilad, “Hyaluronan-CD44 interaction with protein kinase Cε promotes oncogenic signaling by the stem cell marker nanog and the production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells,” The Journal of Biological Chemistry, vol. 284, no. 39, pp. 26533–26546, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Chen, P. Chan, S. Wang, Y. Pan, and H. Chen, “Elevated expression of protein kinase Cδ induces cell scattering upon serum deprivation,” Journal of Cell Science, vol. 123, no. 17, pp. 2901–2913, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. A. K. Gupta, S. S. Galoforo, C. M. Berns et al., “Elevated levels of ERK2 in human breast carcinoma MCF-7 cells transfected with protein kinase Cα,” Cell Proliferation, vol. 29, no. 12, pp. 655–663, 1996. View at Google Scholar · View at Scopus
  41. H. Li, L. Zhao, Z. Yang, J. W. Funder, and J. Liu, “Telomerase is controlled by protein kinase Cα in human breast cancer cells,” The Journal of Biological Chemistry, vol. 273, no. 50, pp. 33436–33442, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Kim, S. H. Thorne, L. Sun, B. Huang, and D. Mochly-Rosen, “Sustained inhibition of PKCα reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model,” Oncogene, vol. 30, no. 3, pp. 323–333, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Kim, J. Han, S. K. Lee et al., “Berberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC-α in breast cancer cells,” Journal of Surgical Research, vol. 176, no. 1, pp. e21–e29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. J. M. Connolly and D. P. Rose, “Expression of the invasive phenotype by MCF-7 human breast cancer cells transfected to overexpress protein kinase C-α or the erbB2 proto-oncogene,” International Journal of Oncology, vol. 10, no. 1, pp. 71–76, 1997. View at Google Scholar · View at Scopus
  45. M. Tan, P. Li, M. Sun, G. Yin, and D. Yu, “Upregulation and activation of PKCα by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKCα and Src inhibitors,” Oncogene, vol. 25, no. 23, pp. 3286–3295, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. J. D. Noti, “Adherence to osteopontin via alphavbeta3 suppresses phorbol ester-mediated apoptosis in MCF-7 breast cancer cells that overexpress protein kinase C-alpha,” International Journal of Oncology, vol. 17, no. 6, pp. 1237–1243, 2000. View at Google Scholar · View at Scopus
  47. D. B. Fournier, M. Chisamore, J. R. Lurain, A. W. Rademaker, V. C. Jordan, and D. A. Tonetti, “Protein kinase C alpha expression is inversely related to ER status in endometrial carcinoma: possible role in AP-1-mediated proliferation of ER-negative endometrial cancer,” Gynecologic Oncology, vol. 81, no. 3, pp. 366–372, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. Z. Li, N. A. Wang, J. Fang et al., “Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells,” Oncology Reports, vol. 27, no. 6, pp. 1879–1886, 2012. View at Google Scholar
  49. J. W. Assender, J. M. W. Gee, I. Lewis, I. O. Ellis, J. F. R. Robertson, and R. I. Nicholson, “Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer,” Journal of Clinical Pathology, vol. 60, no. 11, pp. 1216–1221, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. D. A. Tonetti, W. Gao, D. Escarzaga, K. Walter, A. Szafran, and J. S. Coon, “PKCα and ERβ are associated with triple-negative breast cancers in African American and Caucasian patients,” International Journal of Breast Cancer, vol. 2012, Article ID 740353, 9 pages, 2012. View at Publisher · View at Google Scholar
  51. W. L. Tam, H. Lu, J. Buikhuisen et al., “Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells,” Cancer Cell, vol. 24, no. 3, pp. 347–364, 2013. View at Publisher · View at Google Scholar
  52. D. A. Tonetti, M. Morrow, N. Kidwai, A. Gupta, and S. Badve, “Elevated protein kinase C alpha expression may be predictive of tamoxifen treatment failure,” British Journal of Cancer, vol. 88, no. 9, pp. 1400–1402, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. L. B. Frankel, A. E. Lykkesfeldt, J. B. Hansen, and J. Stenvang, “Protein kinase C α is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells,” Breast Cancer Research and Treatment, vol. 104, no. 2, pp. 165–179, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. X. Lin, Y. Yu, H. Zhao, Y. Zhang, J. Manela, and D. A. Tonetti, “Overexpression of PKCα is required to impart estradiol inhibition and tamoxifen-resistance in a T47D human breast cancer tumor model,” Carcinogenesis, vol. 27, no. 8, pp. 1538–1546, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. N. Wang, Z. Li, F. Tian et al., “PKCα inhibited apoptosis by decreasing the activity of JNK in MCF-7/ADR cells,” Experimental and Toxicologic Pathology, vol. 64, no. 5, pp. 459–464, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. X.-F. Le, M. Marcelli, A. McWatters et al., “Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C α activity,” Oncogene, vol. 20, no. 57, pp. 8258–8269, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. P. K. Gill, A. Gescher, and T. W. Gant, “Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes α and θ,” European Journal of Biochemistry, vol. 268, no. 15, pp. 4151–4157, 2001. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Ahmad and R. I. Glazer, “Expression of the antisense cDNA for protein kinase Cα attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells,” Molecular Pharmacology, vol. 43, no. 6, pp. 858–862, 1993. View at Google Scholar · View at Scopus
  59. I. Carey, C. L. Williams, D. K. Ways, and J. D. M. Noti, “Overexpression of protein kinase C-α in MCF-7 breast cancer cells results in differential regulation and expression of αvβ3 and αvβ5,” International Journal of Oncology, vol. 15, no. 1, pp. 127–136, 1999. View at Google Scholar · View at Scopus
  60. G. K. Lønne, L. Cornmark, I. O. Zahirovic, G. Landberg, K. Jirström, and C. Larsson, “PKCα expression is a marker for breast cancer aggressiveness,” Molecular Cancer, vol. 9, article 76, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. H. Li and I. B. Weinstein, “Protein kinase C β enhances growth and expression of cyclin D1 in human breast cancer cells,” Cancer Research, vol. 66, no. 23, pp. 11399–11408, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. V. C. Grossoni, L. B. Todaro, M. G. Kazanietz, E. D. Bal de Lier Joffé, and A. J. Urtreger, “Opposite effects of protein kinase C beta1 (PKCβ1) and PKCε in the metastatic potential of a breast cancer murine model,” Breast Cancer Research and Treatment, vol. 118, no. 3, pp. 469–480, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. C. Körner, I. Keklikoglou, C. Bender, A. Wörner, and E. Münstermann, “MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C ϵ (PKCϵ),” The Journal of Biological Chemistry, vol. 288, no. 12, pp. 8750–8761, 2013. View at Google Scholar
  64. M. H. Aziz, H. Shen, and C. G. Maki, “Glucocorticoid receptor activation inhibits p53-induced apoptosis of MCF10Amyc cells via induction of protein kinase Cε,” The Journal of Biological Chemistry, vol. 287, no. 35, pp. 29825–29836, 2012. View at Google Scholar
  65. D. Lu, J. Huang, and A. Basu, “Protein kinase Cε activates protein kinase B/Akt via DNA-PK to protect against tumor necrosis factor-α-induced cell death,” The Journal of Biological Chemistry, vol. 281, no. 32, pp. 22799–22807, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. E. Shankar, U. Sivaprasad, and A. Basu, “Protein kinase Cε confers resistance of MCF-7 cells to TRAIL by Akt-dependent activation of Hdm2 and downregulation of p53,” Oncogene, vol. 27, no. 28, pp. 3957–3966, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. L. Huang, H. Cheng, R. Isom, C. Chen, R. A. Levine, and B. U. Pauli, “Protein kinase Cε mediates polymeric fibronectin assembly on the surface of blood-borne rat breast cancer cells to promote pulmonary metastasis,” The Journal of Biological Chemistry, vol. 283, no. 12, pp. 7616–7627, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. D. Pal, S. P. Outram, and A. Basu, “Upregulation of PKCη by PKCε and PDK1 involves two distinct mechanisms and promotes breast cancer cell survival,” Biochimica et Biophysica Acta, vol. 1830, no. 8, pp. 4040–4045, 2013. View at Publisher · View at Google Scholar
  69. G. Karp, A. Maissel, and E. Livneh, “Hormonal regulation of PKC: estrogen up-regulates PKCη expression in estrogen-responsive breast cancer cells,” Cancer Letters, vol. 246, no. 1-2, pp. 173–181, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. G. Karp, S. Abu-Ghanem, V. Novack et al., “Localization of PKCη in cell membranes as a predictor for breast cancer response to treatment,” Onkologie, vol. 35, no. 5, pp. 260–266, 2012. View at Publisher · View at Google Scholar
  71. N. Rotem-Dai, G. Oberkovitz, S. Abu-Ghanem, and E. Livneh, “PKCη confers protection against apoptosis by inhibiting the pro-apoptotic JNK activity in MCF-7 cells,” Experimental Cell Research, vol. 315, no. 15, pp. 2616–2623, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. G. R. Akkaraju and A. Basu, “Overexpression of protein kinase C-η attenuates caspase activation and tumor necrosis factor-α-induced cell death,” Biochemical and Biophysical Research Communications, vol. 279, no. 1, pp. 103–107, 2000. View at Publisher · View at Google Scholar · View at Scopus
  73. P. A. Masso-Welch, J. S. Winston, S. Edge et al., “Altered expression and localization of PKC eta in human breast tumors,” Breast Cancer Research and Treatment, vol. 68, no. 3, pp. 211–223, 2001. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Huang, N. Ouyang, L. Lin et al., “HGF-induced PKCζ activation increases functional CXCR4 expression in human breast cancer cells,” PLoS ONE, vol. 7, no. 1, Article ID e29124, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. P. Yi, Q. Feng, L. Amazit et al., “Atypical protein kinase C regulates dual pathways for degradation of the oncogenic coactivator SRC-3/ AIB1,” Molecular Cell, vol. 29, no. 4, pp. 465–476, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Mao, X. Fang, Y. Lu, R. LaPushin, R. C. Bast Jr., and G. B. Mills, “Inhibition of growth-factor-induced phosphorylation and activation of protein kinase B/Akt by atypical protein kinase C in breast cancer cells,” Biochemical Journal, vol. 352, no. 2, pp. 475–482, 2000. View at Publisher · View at Google Scholar · View at Scopus
  77. K. Belguise, S. Milord, F. Galtier, G. Moquet-Torcy, M. Piechaczyk, and D. Chalbos, “The PKCθ pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells,” Oncogene, vol. 31, no. 47, pp. 4889–4897, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. K. Belguise and G. E. Sonenshein, “PKCθ promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor α synthesis,” The Journal of Clinical Investigation, vol. 117, no. 12, pp. 4009–4021, 2007. View at Publisher · View at Google Scholar · View at Scopus
  79. E. McKiernan, K. O'Brien, N. Grebenchtchikov et al., “Protein kinase Cδ expression in breast cancer as measured by real-time PCR, western blotting and ELISA,” British Journal of Cancer, vol. 99, no. 10, pp. 1644–1650, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. S. Yin, S. Sethi, and K. B. Reddy, “Protein kinase Cδ and caspase-3 modulate TRAIL-induced apoptosis in breast tumor cells,” Journal of Cellular Biochemistry, vol. 111, no. 4, pp. 979–987, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. J. Zhang, N. Liu, J. Zhang, S. Liu, Y. Liu, and D. Zheng, “PKCδ protects human breast tumor MCF-7 cells against tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis,” Journal of Cellular Biochemistry, vol. 96, no. 3, pp. 522–532, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. M. Kim, J. Ju, K. Jang et al., “Protein kinase Cδ negatively regulates Notch1-dependent transcription via a kinase-independent mechanism in vitro,” Biochimica et Biophysica Acta, vol. 1823, no. 2, pp. 387–397, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. Y. S. Kim, H. T. An, J. Kim, and J. Ko, “Effects of protein kinase Cδ and phospholipase C-γ1 on monocyte chemoattractant protein-1 expression in taxol-induced breast cancer cell death,” International Journal of Molecular Medicine, vol. 24, no. 6, pp. 853–858, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. M. I. Díaz Bessone, D. E. Berardi, P. B. Campodónico et al., “Involvement of PKC delta (PKCδ) in the resistance against different doxorubicin analogs,” Breast Cancer Research and Treatment, vol. 126, no. 3, pp. 577–587, 2011. View at Publisher · View at Google Scholar
  85. V. C. Grossoni, K. B. Falbo, M. G. Kazanietz, E. D. Bal de Lier Joffé, and A. J. Urtreger, “Protein kinase C δ enhances proliferation and survival of murine mammary cells,” Molecular Carcinogenesis, vol. 46, no. 5, pp. 381–390, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. S. M. Nabha, S. Glaros, M. Hong et al., “Upregulation of PKC-δ contributes to antiestrogen resistance in mammary tumor cells,” Oncogene, vol. 24, no. 19, pp. 3166–3176, 2005. View at Publisher · View at Google Scholar · View at Scopus
  87. G. K. Lønne, K. C. Masoumi, J. Lennartsson, and C. Larsson, “Protein kinase Cδ supports survival of MDA-MB-231 breast cancer cells by suppressing the ERK1/2 pathway,” The Journal of Biological Chemistry, vol. 284, no. 48, pp. 33456–33465, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. Y. H. Zeidan, B. X. Wu, R. W. Jenkins, L. M. Obeid, and Y. A. Hannun, “A novel role for protein kinase Cδ-mediated phosphorylation of acid sphingomyelinase in UV light-induced mitochondrial injury,” The FASEB Journal, vol. 22, no. 1, pp. 183–193, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. S. A. Lee and M. Jung, “The nucleoside analog sangivamycin induces apoptotic cell death in breast carcinoma MCF7/adriamycin-resistant cells via protein kinase Cδ and JNK activation,” The Journal of Biological Chemistry, vol. 282, no. 20, pp. 15271–15283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. I. Vucenik, G. Ramakrishna, K. Tantivejkul, L. M. Anderson, and D. Ramljak, “Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKCδ-dependent increase in p27Kip1 and decrease in retinoblastoma protein (pRb) phosphorylation,” Breast Cancer Research and Treatment, vol. 91, no. 1, pp. 35–45, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. G. Yokoyama, T. Fujii, K. Tayama, H. Yamana, M. Kuwano, and K. Shirouzu, “PKCδ and MAPK mediate G1 arrest induced by PMA in SKBR-3 breast cancer cells,” Biochemical and Biophysical Research Communications, vol. 327, no. 3, pp. 720–726, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. B. L. Allen-Petersen, C. J. Carter, A. M. Ohm, and M. E. Reyland, “Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer,” Oncogene, vol. 33, no. 10, pp. 1306–1315, 2014. View at Google Scholar
  93. S. Greco, C. Storelli, and S. Marsigliante, “Protein kinase C (PKC)-δ/-ε mediate the PKC/Akt-dependent phosphorylation of extracellular signal-regulated kinases 1 and 2 in MCF-7 cells stimulated by bradykinin,” Journal of Endocrinology, vol. 188, no. 1, pp. 79–89, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. B. de Servi, A. Hermani, S. Medunjanin, and D. Mayer, “Impact of PKCδ on estrogen receptor localization and activity in breast cancer cells,” Oncogene, vol. 24, no. 31, pp. 4946–4955, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. V. G. Keshamouni, R. R. Mattingly, and K. B. Reddy, “Mechanism of 17-β-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 and PKC-δ,” The Journal of Biological Chemistry, vol. 277, no. 25, pp. 22558–22565, 2002. View at Publisher · View at Google Scholar · View at Scopus
  96. M. Shanmugam, N. L. Krett, E. T. Maizels, F. M. Murad, S. T. Rosen, and M. Hunzicker-Dunn, “A role for protein kinase C δ in the differential sensitivity of MCF-7 and MDA-MB 231 human breast cancer cells to phorbol ester-induced growth arrest and p21WAFI/CIP1 induction,” Cancer Letters, vol. 172, no. 1, pp. 43–53, 2001. View at Publisher · View at Google Scholar · View at Scopus
  97. Y. Zuo, Y. Wu, and C. Chakraborty, “Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells,” Journal of Cellular Physiology, vol. 227, no. 4, pp. 1399–1407, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. C. Lin, W. Hou, S. Shen et al., “Quercetin inhibition of tumor invasion via suppressing PKCδ/ERK/ AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells,” Carcinogenesis, vol. 29, no. 9, pp. 1807–1815, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. S. K. Park, Y. S. Hwang, K. Park, H. Park, J. Y. Seo, and W. Chung, “Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCδ-mediated signaling in MCF-7 human breast cancer cells,” Carcinogenesis, vol. 30, no. 7, pp. 1225–1233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. D. Alonso-Escolano, C. Medina, K. Cieslik et al., “Protein kinase Cδ mediates platelet-induced breast cancer cell invasion,” Journal of Pharmacology and Experimental Therapeutics, vol. 318, no. 1, pp. 373–380, 2006. View at Publisher · View at Google Scholar · View at Scopus
  101. D. Jackson, Y. Zheng, D. Lyo et al., “Suppression of cell migration by protein kinase Cδ,” Oncogene, vol. 24, no. 18, pp. 3067–3072, 2005. View at Publisher · View at Google Scholar · View at Scopus
  102. L. A. Davidson, Y.-H. Jiang, J. N. Derr, H. M. Aukema, J. R. Lupton, and R. S. Chapkin, “Protein kinase C isoforms in human and rat colonic mucosa,” Archives of Biochemistry and Biophysics, vol. 312, no. 2, pp. 547–553, 1994. View at Publisher · View at Google Scholar · View at Scopus
  103. S. Doi, D. Goldstein, H. Hug, and I. B. Weinstein, “Expression of multiple isoforms of protein kinase C in normal human colon mucosa and colon tumors and decreased levels of protein kinase C β and η mRNAs in the tumors,” Molecular Carcinogenesis, vol. 11, no. 4, pp. 197–203, 1994. View at Publisher · View at Google Scholar · View at Scopus
  104. J. Pongracz, P. Clark, J. P. Neoptolemos, and J. M. Lord, “Expression of protein kinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids,” International Journal of Cancer, vol. 61, no. 1, pp. 35–39, 1995. View at Publisher · View at Google Scholar · View at Scopus
  105. G. Gobbi, D. di Marcantonio, C. Micheloni et al., “TRAIL up-regulation must be accompanied by a reciprocal PKCε down-regulation during differentiation of colonic epithelial cell: implications for colorectal cancer cell differentiation,” Journal of Cellular Physiology, vol. 227, no. 2, pp. 630–638, 2012. View at Publisher · View at Google Scholar · View at Scopus
  106. I. Heider, B. Schulze, E. Oswald, P. Henklein, J. Scheele, and R. Kaufmann, “PAR1-type thrombin receptor stimulates migration and matrix adhesion of human colon carcinoma cells by a PKCε-dependent mechanism,” Oncology Research, vol. 14, no. 10, pp. 475–482, 2004. View at Google Scholar · View at Scopus
  107. M. L. Saxon, X. Zhao, and J. D. Black, “Activation of protein kinase C isozymes is associated with post-mitotic events in intestinal epithelial cells in situ,” The Journal of Cell Biology, vol. 126, no. 3, pp. 747–763, 1994. View at Publisher · View at Google Scholar · View at Scopus
  108. G. Verstovsek, A. Byrd, M. R. Frey, N. J. Petrelli, and J. D. Black, “Colonocyte differentiation is associated with increased expression and altered distribution of protein kinase C isozymes,” Gastroenterology, vol. 115, no. 1, pp. 75–85, 1998. View at Publisher · View at Google Scholar · View at Scopus
  109. B. Scaglione-Sewell, C. Abraham, M. Bissonnette et al., “Decreased PKC-α expression increases cellular proliferation, decreases differentiation, and enhances the transformed phenotype of CaCo-2 cells,” Cancer Research, vol. 58, no. 5, pp. 1074–1081, 1998. View at Google Scholar · View at Scopus
  110. H. Oster and M. Leitges, “Protein kinase C α but not PKCζ suppresses intestinal tumor formation in ApcMin/+ mice,” Cancer Research, vol. 66, no. 14, pp. 6955–6963, 2006. View at Publisher · View at Google Scholar · View at Scopus
  111. M. A. Pysz, O. V. Leontieva, N. W. Bateman et al., “PKCα tumor suppression in the intestine is associated with transcriptional and translational inhibition of cyclin D1,” Experimental Cell Research, vol. 315, no. 8, pp. 1415–1428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  112. F. Hao, M. A. Pysz, K. J. Curry et al., “Protein kinase Cα signaling regulates inhibitor of DNA binding 1 in the intestinal epithelium,” The Journal of Biological Chemistry, vol. 286, no. 20, pp. 18104–18117, 2011. View at Publisher · View at Google Scholar · View at Scopus
  113. J. Gwak, S. Jung, D. Kang et al., “Stimulation of protein kinase C-α suppresses colon cancer cell proliferation by down-regulation of β-catenin,” Journal of Cellular and Molecular Medicine, vol. 13, no. 8B, pp. 2171–2180, 2009. View at Publisher · View at Google Scholar · View at Scopus
  114. J. M. Lee, I. S. Kim, H. Kim et al., “RORα attenuates Wnt/β-catenin signaling by PKCα-dependent phosphorylation in colon cancer,” Molecular Cell, vol. 37, no. 2, pp. 183–195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  115. B. Wu, H. Zhou, L. Hu, Y. Mu, and Y. Wu, “Involvement of PKCα activation in TF/VIIa/PAR2-induced proliferation, migration, and survival of colon cancer cell SW620,” Tumor Biology, vol. 34, no. 2, pp. 837–846, 2013. View at Google Scholar
  116. K. Masur, K. Lang, B. Niggemann, K. S. Zanker, and F. Entschladen, “High PKC α and low E-cadherin expression contribute to high migratory activity of colon carcinoma cells,” Molecular Biology of the Cell, vol. 12, no. 7, pp. 1973–1982, 2001. View at Google Scholar · View at Scopus
  117. S. Chakrabarty, S. Rajagopal, and T. L. Moskal, “Protein kinase Cα controls the adhesion but not the antiproliferative response of human colon carcinoma cells to transforming growth factor β1: identification of two distinct branches of post-protein kinase Cα adhesion signal pathway,” Laboratory Investigation, vol. 78, no. 4, pp. 413–421, 1998. View at Google Scholar · View at Scopus
  118. H. Wang and S. Chakrabarty, “Requirement of protein kinase Cα, extracellular matrix remodeling, and cell-matrix interaction for transforming growth factorβ-regulated expression of E-cadherin and catenins,” Journal of Cellular Physiology, vol. 187, no. 2, pp. 188–195, 2001. View at Publisher · View at Google Scholar · View at Scopus
  119. K. R. Gravitt, N. E. Ward, D. Fan, J. M. Skibber, B. Levin, and C. A. O'Brian, “Evidence that protein kinase C-α activation is a critical event in phorbol ester-induced multiple drug resistance in human colon cancer cells,” Biochemical Pharmacology, vol. 48, no. 2, pp. 375–381, 1994. View at Publisher · View at Google Scholar · View at Scopus
  120. S. K. Lee, A. Shehza, J. C. Jung et al., “Protein kinase Cα protects against multidrug resistance in human colon cancer cells,” Molecules and Cells, vol. 34, no. 1, pp. 61–69, 2012. View at Google Scholar
  121. C. A. M. la Porta, E. Dolfini, and R. Comolli, “Inhibition of protein kinase C-α isoform enhances the P-glycoprotein expression and the survival of LoVo human colon adenocarcinoma cells to doxorubicin exposure,” British Journal of Cancer, vol. 78, no. 10, pp. 1283–1287, 1998. View at Google Scholar · View at Scopus
  122. S. Chakrabarty and S. Huang, “Modulation of chemosensitivity in human colon carcinoma cells by downregulating protein kinase Cα expression,” Journal of Experimental Therapeutics and Oncology, vol. 1, no. 4, pp. 218–221, 1996. View at Google Scholar · View at Scopus
  123. N. R. Murray, L. A. Davidson, R. S. Chapkin, W. C. Gustafson, D. G. Schattenberg, and A. P. Fields, “Overexpression of protein kinase C β(II) induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis,” The Journal of Cell Biology, vol. 145, no. 4, pp. 699–711, 1999. View at Publisher · View at Google Scholar · View at Scopus
  124. N. R. Murray, C. Weems, L. Chen et al., “Protein kinase C βII and TGFβRII in ω-3 fatty acid-mediated inhibition of colon carcinogenesis,” The Journal of Cell Biology, vol. 157, no. 6, pp. 915–920, 2002. View at Publisher · View at Google Scholar · View at Scopus
  125. Y. Gökmen-Polar, N. R. Murray, M. A. Velasco, Z. Gatalica, and A. P. Fields, “Elevated protein kinase C βII is an early promotive event in colon carcinogenesis,” Cancer Research, vol. 61, no. 4, pp. 1375–1381, 2001. View at Google Scholar · View at Scopus
  126. Y. Liu, W. Su, E. A. Thompson, M. Leitges, N. R. Murray, and A. P. Fields, “Protein kinase C βII regulates its own expression in rat intestinal epithelial cells and the colonic epithelium in vivo,” The Journal of Biological Chemistry, vol. 279, no. 44, pp. 45556–45563, 2004. View at Publisher · View at Google Scholar · View at Scopus
  127. W. Yu, N. R. Murray, C. Weems et al., “Role of cyclooxygenase 2 in protein kinase C βII-mediated colon carcinogenesis,” The Journal of Biological Chemistry, vol. 278, no. 13, pp. 11167–11174, 2003. View at Publisher · View at Google Scholar · View at Scopus
  128. J. Zhang, P. Z. Anastasiadis, Y. Liu, E. A. Thompson, and A. P. Fields, “Protein kinase c (PKC) βII induces cell invasion through a Ras/Mek-, PKCι/Rac 1-dependent signaling pathway,” The Journal of Biological Chemistry, vol. 279, no. 21, pp. 22118–22123, 2004. View at Publisher · View at Google Scholar · View at Scopus
  129. L. A. Davidson, R. E. Brown, W. L. Chang et al., “Morphodensitometric analysis of protein kinase C βII expression in rat colon: modulation by diet and relation to in situ cell proliferation and apoptosis,” Carcinogenesis, vol. 21, no. 8, pp. 1513–1519, 2000. View at Google Scholar · View at Scopus
  130. P. Cesaro, E. Raiteri, M. Démoz et al., “Expression of protein kinase C β1 confers resistance to TNFα- and paclitaxel-induced apoptosis in HT-29 colon carcinoma cells,” International Journal of Cancer, vol. 93, no. 2, pp. 179–184, 2001. View at Publisher · View at Google Scholar · View at Scopus
  131. H. Lee, J. Ghose-Dastidar, S. Winawer, and E. Friedman, “Signal transduction through extracellular signal-regulated kinase-like pp57 blocked in differentiated cells having low protein kinase Cβ activity,” The Journal of Biological Chemistry, vol. 268, no. 7, pp. 5255–5263, 1993. View at Google Scholar · View at Scopus
  132. S. Sauma, Z. Yan, S. Ohno, and E. Friedman, “Protein kinase Cβ1 and protein kinase Cβ2 activate p57 mitogen- activated protein kinase and block differentiation in colon carcinoma cells,” Cell Growth & Differentiation, vol. 7, no. 5, pp. 587–594, 1996. View at Google Scholar · View at Scopus
  133. A. P. Fields, S. R. Calcagno, M. Krishna, S. Rak, M. Leitges, and N. R. Murray, “Protein kinase cβ is an effective target for chemoprevention of colon cancer,” Cancer Research, vol. 69, no. 4, pp. 1643–1650, 2009. View at Publisher · View at Google Scholar · View at Scopus
  134. N. R. Murray, L. Jamieson, W. Yu et al., “Protein kinase Cι is required for Ras transformation and colon carcinogenesis in vivo,” The Journal of Cell Biology, vol. 164, no. 6, pp. 797–802, 2004. View at Publisher · View at Google Scholar · View at Scopus
  135. N. R. Murray, J. Weems, U. Braun, M. Leitges, and A. P. Fields, “Protein kinase C βII and PKCι/λ: collaborating partners in colon cancer promotion and progression,” Cancer Research, vol. 69, no. 2, pp. 656–662, 2009. View at Publisher · View at Google Scholar · View at Scopus
  136. S. I. Oikarinen, A. Pajari, I. Salminen, S. Heinonen, H. Adlercreutz, and M. Mutanen, “Effects of a flaxseed mixture and plant oils rich in α-linolenic acid on the adenoma formation in multiple intestinal neoplasia (Min) mice,” British Journal of Nutrition, vol. 94, no. 4, pp. 510–518, 2005. View at Publisher · View at Google Scholar · View at Scopus
  137. R. Mustafi, S. Cerda, A. Chumsangsri, A. Fichera, and M. Bissonnette, “Protein kinase-ζ inhibits collagen I-dependent and anchorage-independent growth and enhances apoptosis of human Caco-2 cells,” Molecular Cancer Research, vol. 4, no. 9, pp. 683–694, 2006. View at Publisher · View at Google Scholar · View at Scopus
  138. L. Ma, Y. Tao, A. Duran et al., “Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesis,” Cell, vol. 152, no. 3, pp. 599–611, 2013. View at Publisher · View at Google Scholar
  139. L. B. Luna-Ulloa, J. G. Hernández-Maqueda, P. Santoyo-Ramos, M. C. Castañeda-Patlán, and M. Robles-Flores, “Protein kinase C ζ is a positive modulator of canonical wnt signaling pathway in tumoral colon cell lines,” Carcinogenesis, vol. 32, no. 11, pp. 1615–1624, 2011. View at Publisher · View at Google Scholar · View at Scopus
  140. Y. Qin, Y. Tang, A. V. Schally, and B. S. Beckman, “Dexniguldipine hydrochloride inhibits growth of human HT-29 colon carcinoma cells and expression of protein kinase C Δ and ζ,” International Journal of Oncology, vol. 7, no. 5, pp. 1073–1077, 1995. View at Google Scholar · View at Scopus
  141. H. K. Roy, M. Bissonnette, B. P. Frawley Jr. et al., “Selective preservation of protein kinase C-ζ in the chemoprevention of azoxymethane-induced colonic tumors by piroxicam,” FEBS Letters, vol. 366, no. 2-3, pp. 143–145, 1995. View at Publisher · View at Google Scholar · View at Scopus
  142. J. G. Hernández-Maqueda, L. B. Luna-Ulloa, P. Santoyo-Ramos, M. C. Castañeda-Patlán, and M. Robles-Flores, “Protein kinase C delta negatively modulates canonical Wnt pathway and cell proliferation in colon tumor cell lines,” PLoS ONE, vol. 8, no. 3, Article ID e58540, 2013. View at Google Scholar
  143. G. Perletti, E. Marras, D. Osti, L. Felici, S. Zaro, and M. de Eguileor, “PKCδ requires p53 for suppression of the transformed phenotype in human colon cancer cells,” Journal of Cellular and Molecular Medicine, vol. 8, no. 4, pp. 563–569, 2004. View at Google Scholar · View at Scopus
  144. G. Perletti, E. Marras, D. Dondi et al., “p21Waf1/Cip1 and p53 are downstream effectors of protein kinase C delta in tumor suppression and differentiation in human colon cancer cells,” International Journal of Cancer, vol. 113, no. 1, pp. 42–53, 2005. View at Publisher · View at Google Scholar · View at Scopus
  145. Y. H. Kim, J. H.. Lim, T. J. Lee, J. W. Park, and T. K. Kwon, “Expression of cyclin D3 through Sp1 sites by histone deacetylase inhibitors is mediated with protein kinase C-δ (PKC-δ) signal pathway,” Journal of Cellular Biochemistry, vol. 101, no. 4, pp. 987–995, 2007. View at Publisher · View at Google Scholar · View at Scopus
  146. S. R. Cerda, R. Mustafi, H. Little et al., “Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators,” Oncogene, vol. 25, no. 22, pp. 3123–3138, 2006. View at Publisher · View at Google Scholar · View at Scopus
  147. S. R. Cerda, M. Bissonnette, B. Scaglione-Sewell et al., “PKC-δ inhibits anchorage-dependent and -independent growth, enhances differentiation, and increases apoptosis in CaCo-2 cells,” Gastroenterology, vol. 120, no. 7, pp. 1700–1712, 2001. View at Google Scholar · View at Scopus
  148. A. E. Lewis, R. Susarla, B. C. Y. Wong, M. J. S. Langman, and M. C. Eggo, “Protein kinase C delta is not activated by caspase-3 and its inhibition is sufficient to induce apoptosis in the colon cancer line, COLO 205,” Cellular Signalling, vol. 17, no. 2, pp. 253–262, 2005. View at Publisher · View at Google Scholar · View at Scopus
  149. Q. Wang, X. Wang, and B. M. Evers, “Induction of cIAP-2 in human colon cancer cells through PKCδ/NF-κB,” The Journal of Biological Chemistry, vol. 278, no. 51, pp. 51091–51099, 2003. View at Publisher · View at Google Scholar · View at Scopus
  150. Q. Wang, X. Wang, Y. Zhou, and B. M. Evers, “PKCδ-mediated regulation of FLIP expression in human colon cancer cells,” International Journal of Cancer, vol. 118, no. 2, pp. 326–334, 2006. View at Publisher · View at Google Scholar · View at Scopus
  151. D. H. Kho, J. A. Bae, J. H.. Lee et al., “KITENIN recruits Dishevelled/PKCd to form a functional complex and controls the migration and invasiveness of colorectal cancer cells,” Gut, vol. 58, no. 4, pp. 509–519, 2009. View at Publisher · View at Google Scholar · View at Scopus
  152. M. Park, W. K. Kim, M. Song et al., “Protein kinase C-δ-mediated recycling of active KIT in colon cancer,” Clinical Cancer Research, vol. 19, no. 18, pp. 4961–4971, 2013. View at Publisher · View at Google Scholar
  153. A. Doller, S. Schulz, J. Pfeilschifter, and W. Eberhardt, “RNA-dependent association with myosin IIA promotes F-actin-guided trafficking of the ELAV-like protein HuR to polysomes,” Nucleic Acids Research, vol. 41, no. 19, pp. 9152–9167, 2013. View at Google Scholar
  154. A. Sadok, V. Bourgarel-Rey, F. Gattacceca, C. Penel, M. Lehmann, and H. Kovacic, “Nox1-dependent superoxide production controls colon adenocarcinoma cell migration,” Biochimica et Biophysica Acta, vol. 1783, no. 1, pp. 23–33, 2008. View at Publisher · View at Google Scholar · View at Scopus
  155. S. C. Lin, W. Y. Chen, K. Y. Lin et al., “Clinicopathological correlation and prognostic significance of protein kinase Cα overexpression in human gastric carcinoma,” PLoS ONE, vol. 8, no. 2, Article ID e56675, 2013. View at Google Scholar
  156. K. Lin, C. Fang, Y. Uen et al., “Overexpression of protein kinase Cα mRNA may be an independent prognostic marker for gastric carcinoma,” Journal of Surgical Oncology, vol. 97, no. 6, pp. 538–543, 2008. View at Publisher · View at Google Scholar · View at Scopus
  157. Y. Han, Z. Han, X. Zhou et al., “Expression and function of classical protein kinase C isoenzymes in gastric cancer cell line and its drug-resistant sublines,” World Journal of Gastroenterology, vol. 8, no. 3, pp. 441–445, 2002. View at Google Scholar · View at Scopus
  158. D. Wu, F. Sui, C. Du et al., “Antisense expression of PKCα improved sensitivity of SGC7901/VCR cells to doxorubicin,” World Journal of Gastroenterology, vol. 15, no. 10, pp. 1259–1263, 2009. View at Publisher · View at Google Scholar · View at Scopus
  159. X. Jiang, S. Tu, J. Cui et al., “Antisense targeting protein kinase C α and β1 inhibits gastric carcinogenesis,” Cancer Research, vol. 64, no. 16, pp. 5787–5794, 2004. View at Publisher · View at Google Scholar · View at Scopus
  160. M. J. Redlak, J. J. Power, and T. A. Miller, “Aspirin-induced apoptosis in human gastric cancer epithelial cells: relationship with protein kinase C signaling,” Digestive Diseases and Sciences, vol. 52, no. 3, pp. 810–816, 2007. View at Publisher · View at Google Scholar · View at Scopus
  161. M. J. Atten, E. Godoy-Romero, B. M. Attar, T. Milson, M. Zopel, and O. Holian, “Resveratrol regulates cellular PKC α and δ to inhibit growth and induce apoptosis in gastric cancer cells,” Investigational New Drugs, vol. 23, no. 2, pp. 111–119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  162. H. Okuda, M. Adachi, M. Miyazawa, Y. Hinoda, and K. Imai, “Protein kinase Cα promotes apoptotic cell death in gastric cancer cells depending upon loss of anchorage,” Oncogene, vol. 18, no. 40, pp. 5604–5609, 1999. View at Publisher · View at Google Scholar · View at Scopus
  163. B. Zhang and C. Xia, “12-O-tetradecanoylphorbol-1,3-acetate induces the negative regulation of protein kinase B by protein kinase Cα during gastric cancer cell apoptosis,” Cellular and Molecular Biology Letters, vol. 15, no. 3, pp. 377–394, 2010. View at Publisher · View at Google Scholar · View at Scopus
  164. G. H. Zhu, B. C. Y. Wong, E. D. Slosberg et al., “Overexpression of protein kinase C-β1 isoenzyme suppresses indomethacin-induced apoptosis in gastric epithelial cells,” Gastroenterology, vol. 118, no. 3, pp. 507–514, 2000. View at Google Scholar · View at Scopus
  165. X. Jiang, S. Lam, M. C. M. Lin et al., “Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-β1-dependent pathway,” Oncogene, vol. 21, no. 39, pp. 6113–6122, 2002. View at Publisher · View at Google Scholar · View at Scopus
  166. K. W. Lee, S. G. Kim, H. P. Kim et al., “Enzastaurin, a protein kinase Cβ inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells,” Cancer Research, vol. 68, no. 6, pp. 1916–1926, 2008. View at Publisher · View at Google Scholar · View at Scopus
  167. M. Lisovsky, F. Ogawa, K. Dresser, B. Woda, and G. Y. Lauwers, “Loss of cell polarity protein Lgl2 in foveolar-type gastric dysplasia: correlation with expression of the apical marker aPKC-zeta,” Virchows Archiv, vol. 457, no. 6, pp. 635–642, 2010. View at Publisher · View at Google Scholar · View at Scopus
  168. R. Takagawa, K. Akimoto, Y. Ichikawa et al., “High expression of atypical protein kinase C λ/ι in gastric cancer as a prognostic factor for recurrence,” Annals of Surgical Oncology, vol. 17, no. 1, pp. 81–88, 2010. View at Publisher · View at Google Scholar · View at Scopus
  169. Y. Yoshihama, Y. Izumisawa, K. Akimoto et al., “High expression of KIBRA in low atypical protein kinase C-expressing gastric cancer correlates with lymphatic invasion and poor prognosis,” Cancer Science, vol. 104, no. 2, pp. 259–265, 2013. View at Publisher · View at Google Scholar
  170. Y. Iioka, K. Mishima, N. Azuma et al., “Overexpression of protein kinase Cδ enhances cisplatin-induced cytotoxicity correlated with p53 in gastric cancer cell line,” Pathobiology, vol. 72, no. 3, pp. 152–159, 2005. View at Publisher · View at Google Scholar · View at Scopus
  171. T. Kanno, T. Nishimoto, Y. Fujita, A. Gotoh, T. Nakano, and T. Nishizaki, “Sphingosine induces apoptosis in MKN-28 human gastric cancer cells in an SDK-dependent manner,” Cellular Physiology and Biochemistry, vol. 30, pp. 987–994, 2012. View at Google Scholar
  172. M. Lee, T. Y. Kim, Y. Kim et al., “The signaling network of transforming growth factor β1, protein kinase Cδ and integrin underlies the spreading and invasiveness of gastric carcinoma cells,” Molecular and Cellular Biology, vol. 25, no. 16, pp. 6921–6936, 2005. View at Publisher · View at Google Scholar · View at Scopus
  173. H. E. Lee, M. A. Kim, H. S. Lee, B. L. Lee, and W. H. Kim, “Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining,” Journal of Clinical Pathology, vol. 61, no. 6, pp. 722–729, 2008. View at Publisher · View at Google Scholar · View at Scopus
  174. P. Blay, A. Astudillo, J. M. Buesa et al., “Protein kinase C θ is highly expressed in gastrointestinal stromal tumors but not in other mesenchymal neoplasias,” Clinical Cancer Research, vol. 10, no. 12, part 1, pp. 4089–4095, 2004. View at Publisher · View at Google Scholar · View at Scopus
  175. W.-B. Ou, M.-J. Zhu, G. D. Demetri, C. D. M. Fletcher, and J. A. Fletcher, “Protein kinase C-θ regulates KIT expression and proliferation in gastrointestinal stromal tumors,” Oncogene, vol. 27, no. 42, pp. 5624–5634, 2008. View at Publisher · View at Google Scholar · View at Scopus
  176. A. Motegi, S. Sakurai, H. Nakayama, T. Sano, T. Oyama, and T. Nakajima, “PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT-negative tumors,” Pathology International, vol. 55, no. 3, pp. 106–112, 2005. View at Publisher · View at Google Scholar · View at Scopus
  177. G. Kang, A. Srivastava, Y. E. Kim et al., “DOG1 and PKC-θ-are useful in the diagnosis of KIT-negative gastrointestinal stromal tumors,” Modern Pathology, vol. 24, no. 6, pp. 866–875, 2011. View at Publisher · View at Google Scholar · View at Scopus
  178. C. Wang, M. S. Jin, Y. B. Zou et al., “Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours,” Scandinavian Journal of Gastroenterology, vol. 48, no. 9, pp. 1055–1065, 2013. View at Publisher · View at Google Scholar
  179. K. Kim, D. W. Kang, W. S. Moon et al., “PKCθ expression in gastrointestinal stromal tumor,” Modern Pathology, vol. 19, no. 11, pp. 1480–1486, 2006. View at Publisher · View at Google Scholar · View at Scopus
  180. M. J. Ríos-Moreno, S. Jaramillo, S. Pereira Gallardo et al., “Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Is there any advantage in using several markers?” Pathology Research and Practice, vol. 208, no. 2, pp. 74–81, 2012. View at Publisher · View at Google Scholar · View at Scopus
  181. P. Y. Wen and S. Kesari, “Malignant gliomas in adults,” The New England Journal of Medicine, vol. 359, no. 5, pp. 492–507, 2008. View at Publisher · View at Google Scholar · View at Scopus
  182. C.-C. Chen, “Protein kinase Cα, δ, ε and ζ in C6 glioma cells. TPA induces translocation and down-regulation of conventional and new PKC isoforms but not atypical PKC ζ,” FEBS Letters, vol. 332, no. 1-2, pp. 169–173, 1993. View at Publisher · View at Google Scholar · View at Scopus
  183. M. I. González, B. T. S. Susarla, and M. B. Robinson, “Evidence that protein kinase Cα interacts with and regulates the glial glutamate transporter GLT-1,” Journal of Neurochemistry, vol. 94, no. 5, pp. 1180–1188, 2005. View at Publisher · View at Google Scholar · View at Scopus
  184. H. Xiao, D. A. Goldthwait, and T. Mapstone, “The identification of four protein kinase C isoforms in human glioblastoma cell lines: PKC alpha, gamma, epsilon, and zeta,” Journal of Neurosurgery, vol. 81, no. 5, pp. 734–740, 1994. View at Google Scholar · View at Scopus
  185. A. Misra-Press, A. P. Fields, D. Samols, and D. A. Goldthwait, “Protein kinase C isoforms in human glioblastoma cells,” Glia, vol. 6, no. 3, pp. 188–197, 1992. View at Google Scholar · View at Scopus
  186. R. Mandil, E. Ashkenazi, M. Blass et al., “Protein kinase Cα and protein kinase Cδ play opposite roles in the proliferation and apoptosis of glioma cells,” Cancer Research, vol. 61, no. 11, pp. 4612–4619, 2001. View at Google Scholar · View at Scopus
  187. T. Todo, N. Shitara, H. Nakamura, K. Takakura, and K. Ikeda, “Immunohistochemical demonstration of protein kinase C isozymes in human brain tumors,” Neurosurgery, vol. 29, no. 3, pp. 399–404, 1991. View at Google Scholar · View at Scopus
  188. D. L. Benzil, S. D. Finkelstein, M. H. Epstein, and P. W. Finch, “Expression pattern of α-protein kinase C in human astrocytomas indicates a role in malignant progression,” Cancer Research, vol. 52, no. 10, pp. 2951–2956, 1992. View at Google Scholar · View at Scopus
  189. M. Leirdal and M. Sioud, “Protein kinase Cα isoform regulates the activation of the MAP kinase ERK1/2 in human glioma cells: involvement in cell survival and gene expression,” Molecular Cell Biology Research Communications, vol. 4, no. 2, pp. 106–110, 2000. View at Publisher · View at Google Scholar · View at Scopus
  190. Q. Fan, C. Cheng, Z. A. Knight et al., “EGFR signals to mTOR through PKC and independently of Akt in glioma,” Science Signaling, vol. 2, no. 55, article ra4, 2009. View at Publisher · View at Google Scholar · View at Scopus
  191. A. J. Cameron, K. J. Procyk, M. Leitges, and P. J. Parker, “PKC alpha protein but not kinase activity is critical for glioma cell proliferation and survival,” International Journal of Cancer, vol. 123, no. 4, pp. 769–779, 2008. View at Publisher · View at Google Scholar · View at Scopus
  192. R. Sattler, B. Tyler, B. Hoover et al., “Increased expression of glutamate transporter GLT-1 in peritumoral tissue associated with prolonged survival and decreases in tumor growth in a rat model of experimental malignant glioma,” Journal of Neurosurgery, vol. 119, no. 4, pp. 878–886, 2013. View at Publisher · View at Google Scholar
  193. M. I. González, P. G. Bannerman, and M. B. Robinson, “Phorbol myristate acetate-dependent interaction of protein kinase Cα and the neuronal glutamate transporter EAAC1,” Journal of Neuroscience, vol. 23, no. 13, pp. 5589–5593, 2003. View at Google Scholar · View at Scopus
  194. Y. Huang and Z. Zuo, “Isoflurane induces a protein kinase C α-dependent increase in cell-surface protein level and activity of glutamate transporter type 3,” Molecular Pharmacology, vol. 67, no. 5, pp. 1522–1533, 2005. View at Publisher · View at Google Scholar · View at Scopus
  195. A. M. Donson, A. Banerjee, F. Gamboni-Robertson, J. M. Fleitz, and N. K. Foreman, “Protein kinase C ζ isoform is critical for proliferation in human glioblastoma cell lines,” Journal of Neuro-Oncology, vol. 47, no. 2, pp. 109–115, 2000. View at Publisher · View at Google Scholar · View at Scopus
  196. S. Singh, T. Okamura, and F. Ali-Osman, “Serine phosphorylation of glutathione S-transferase P1 (GSTP1) by PKCα enhances GSTP1-dependent cisplatin metabolism and resistance in human glioma cells,” Biochemical Pharmacology, vol. 80, no. 9, pp. 1343–1355, 2010. View at Publisher · View at Google Scholar · View at Scopus
  197. D. R. Sorensen, M. Leirdal, P. O. Iversen, and M. Sioud, “Combination of endostatin and a protein kinase Cα DNA enzyme improves the survival of rats with malignant glioma,” Neoplasia, vol. 4, no. 6, pp. 474–479, 2002. View at Publisher · View at Google Scholar · View at Scopus
  198. M. Leirdal and M. Sioud, “Ribozyme inhibition of the protein kinase Cα triggers apoptosis in glioma cells,” British Journal of Cancer, vol. 80, no. 10, pp. 1558–1564, 1999. View at Google Scholar · View at Scopus
  199. S. A. Grossman, J. B. Alavi, J. G. Supko et al., “Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-α delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas,” Neuro-Oncology, vol. 7, no. 1, pp. 32–40, 2005. View at Publisher · View at Google Scholar · View at Scopus
  200. C. Lin, S. Shen, C. Chien, L. Yang, L. Shia, and Y. Chen, “12-O-tetradecanoylphorbol-13-acetate-induced invasion/migration of glioblastoma cells through activating PKCα/ERK/NF-κB-dependent MMP-9 expression,” Journal of Cellular Physiology, vol. 225, no. 2, pp. 472–481, 2010. View at Publisher · View at Google Scholar · View at Scopus
  201. S. Amos, M. Mut, C. G. diPierro et al., “Protein kinase C-α-mediated regulation of low-density lipoprotein receptor-related protein and urokinase increases astrocytoma invasion,” Cancer Research, vol. 67, no. 21, pp. 10241–10251, 2007. View at Publisher · View at Google Scholar · View at Scopus
  202. Z. A. Kohutek, C. G. diPierro, G. T. Redpath, and I. M. Hussaini, “ADAM-10-mediated N-cadherin cleavage is protein kinase C-α dependent and promotes glioblastoma cell migration,” Journal of Neuroscience, vol. 29, no. 14, pp. 4605–4615, 2009. View at Publisher · View at Google Scholar · View at Scopus
  203. I. T. Makagiansar, S. Williams, T. Mustelin, and W. B. Stallcup, “Differential phosphorylation of NG2 proteoglycan by ERK and PKCα helps balance cell proliferation and migration,” The Journal of Cell Biology, vol. 178, no. 1, pp. 155–165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  204. A. Ziv-Av, D. Taller, M. Attia et al., “RTVP-1 expression is regulated by SRF downstream of protein kinase C and contributes to the effect of SRF on glioma cell migration,” Cellular Signalling, vol. 23, no. 12, pp. 1936–1943, 2011. View at Publisher · View at Google Scholar · View at Scopus
  205. T. R. Sharif and M. Sharif, “Overexpression of protein kinase C epsilon in astroglial brain tumor derived cell lines and primary tumor samples,” International Journal of Oncology, vol. 15, no. 2, pp. 237–243, 1999. View at Google Scholar · View at Scopus
  206. S. Kahana, S. Finniss, S. Cazacu et al., “Proteasome inhibitors sensitize glioma cells and glioma stem cells to TRAIL-induced apoptosis by PKCε-dependent downregulation of AKT and XIAP expressions,” Cellular Signalling, vol. 23, no. 8, pp. 1348–1357, 2011. View at Publisher · View at Google Scholar · View at Scopus
  207. H. Shinohara, N. Kayagaki, H. Yagita et al., “A protective role of PKCε against TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in glioma cells,” Biochemical and Biophysical Research Communications, vol. 284, no. 5, pp. 1162–1167, 2001. View at Publisher · View at Google Scholar · View at Scopus
  208. M. H. Aziz, B. B. Hafeez, J. M. Sand et al., “Protein kinase Cε mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2),” Oncogene, vol. 29, no. 21, pp. 3100–3109, 2010. View at Publisher · View at Google Scholar · View at Scopus
  209. S. Fortin, M. le Mercier, I. Camby et al., “Galectin-1 is implicated in the protein kinase c ε/vimentin-controlled trafficking of integrin-β1 in glioblastoma cells,” Brain Pathology, vol. 20, no. 1, pp. 39–49, 2010. View at Publisher · View at Google Scholar · View at Scopus
  210. A. Besson, A. Davy, S. M. Robbins, and V. W. Yong, “Differential activation of ERKs to focal adhesions by PKC ε is required for PMA-induced adhesion and migration of human glioma cells,” Oncogene, vol. 20, no. 50, pp. 7398–7407, 2001. View at Publisher · View at Google Scholar · View at Scopus
  211. T. R. Sharif, N. Sasakawa, and M. Sharif, “Regulated expression of a dominant negative protein kinase C epsilon mutant inhibits the proliferation of U-373MG human astrocytoma cells,” International Journal of Molecular Medicine, vol. 7, no. 4, pp. 373–380, 2001. View at Google Scholar · View at Scopus
  212. K. Alapati, S. Gopinath, R. Malla, V. R. Dasari, and J. Rao, “uPAR and cathepsin B knockdown inhibits radiation-induced PKC integrated integrin signaling to the cytoskeleton of glioma-initiating cells,” International Journal of Oncology, vol. 41, no. 2, pp. 599–610, 2012. View at Publisher · View at Google Scholar
  213. H. Guo, F. Gu, W. Li et al., “Reduction of protein kinase C ζ inhibits migration and invasion of human glioblastoma cells,” Journal of Neurochemistry, vol. 109, no. 1, pp. 203–213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  214. H. Huang, C. Huang, S. Lin-Shiau, and J. Lin, “Ursolic acid inhibits IL-1β or TNF-α-induced C6 glioma invasion through suppressing the association ZIP/p62 with PKC-ζ and downregulating the MMP-9 expression,” Molecular Carcinogenesis, vol. 48, no. 6, pp. 517–531, 2009. View at Publisher · View at Google Scholar · View at Scopus
  215. P. O. Estève, É. Chicoine, O. Robledo et al., “Protein kinase C-ζ regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-α in glioma cells via NF-κB,” The Journal of Biological Chemistry, vol. 277, no. 38, pp. 35150–35155, 2002. View at Publisher · View at Google Scholar · View at Scopus
  216. K. van Kolen and H. Slegers, “Atypical PKCζ is involved in RhoA-dependent mitogenic signaling by the P2Y12 receptor in C6 cells,” The FEBS Journal, vol. 273, no. 8, pp. 1843–1854, 2006. View at Publisher · View at Google Scholar · View at Scopus
  217. M. Guizzetti and L. G. Costa, “Effect of ethanol on protein kinase Cζ and p70S6 kinase activation by carbachol: a possible mechanism for ethanol-induced inhibition of glial cell proliferation,” Journal of Neurochemistry, vol. 82, no. 1, pp. 38–46, 2002. View at Publisher · View at Google Scholar · View at Scopus
  218. R. Patel, H. Win, S. Desai, K. Patel, J. A. Matthews, and M. Acevedo-Duncan, “Involvement of PKC-ι in glioma proliferation,” Cell Proliferation, vol. 41, no. 1, pp. 122–135, 2008. View at Publisher · View at Google Scholar · View at Scopus
  219. E. Bicaku, R. Patel, and M. Acevedo-Duncan, “Cyclin-dependent kinase activating kinase/Cdk7 co-localizes with PKC-ι in human glioma cells,” Tissue and Cell, vol. 37, no. 1, pp. 53–58, 2005. View at Publisher · View at Google Scholar · View at Scopus
  220. S. R. Desai, P. P. Pillai, R. S. Patel, A. N. McCray, H. Y. Win-Piazza, and M. E. Acevedo-Duncan, “Regulation of Cdk7 activity through a phosphatidylinositol (3)-kinase/PKC-ι-mediated signaling cascade in glioblastoma,” Carcinogenesis, vol. 33, no. 1, pp. 10–19, 2012. View at Publisher · View at Google Scholar · View at Scopus
  221. S. Desai, P. Pillai, H. Win-Piazza, and M. Acevedo-Duncan, “PKC-3 promotes glioblastoma cell survival by phosphorylating and inhibiting BAD through a phosphatidylinositol 3-kinase pathway,” Biochimica et Biophysica Acta, vol. 1813, no. 6, pp. 1190–1197, 2011. View at Publisher · View at Google Scholar · View at Scopus
  222. R. M. Baldwin, M. Garratt-Lalonde, D. A. E. Parolin, P. M. Krzyzanowski, M. A. Andrade, and I. A. J. Lorimer, “Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Cι-mediated attenuation of p38 MAP kinase signaling,” Oncogene, vol. 25, no. 20, pp. 2909–2919, 2006. View at Publisher · View at Google Scholar · View at Scopus
  223. R. M. Baldwin, D. A. E. Parolin, and I. A. J. Lorimer, “Regulation of glioblastoma cell invasion by PKCι and RhoB,” Oncogene, vol. 27, no. 25, pp. 3587–3595, 2008. View at Publisher · View at Google Scholar · View at Scopus
  224. R. M. Uht, S. Amos, P. M. Martin, A. E. Riggan, and I. M. Hussaini, “The protein kinase C-η isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway,” Oncogene, vol. 26, no. 20, pp. 2885–2893, 2007. View at Publisher · View at Google Scholar · View at Scopus
  225. S. E. Aeder, P. M. Martin, J. Soh, and I. M. Hussaini, “PKC-η mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways,” Oncogene, vol. 23, no. 56, pp. 9062–9069, 2004. View at Publisher · View at Google Scholar · View at Scopus
  226. P. M. Martin, S. E. Aeder, C. A. Chrestensen, T. W. Sturgill, and I. M. Hussaini, “Phorbol 12-myristate 13-acetate and serum synergize to promote rapamycin-insensitive cell proliferation via protein kinase C-eta,” Oncogene, vol. 26, no. 3, pp. 407–414, 2007. View at Publisher · View at Google Scholar · View at Scopus
  227. I. M. Hussaini, J. E. Carpenter, G. T. Redpath, J. J. Sando, M. E. Shaffrey, and S. R. VandenBerg, “Protein kinase C-η regulates resistance to UV- and γ-irradiation-induced apoptosis in glioblastoma cells by preventing caspase-9 activation,” Neuro-Oncology, vol. 4, no. 1, pp. 9–21, 2002. View at Publisher · View at Google Scholar · View at Scopus
  228. W. Lu, H. Lee, C. Xiang, S. Finniss, and C. Brodie, “The phosphorylation of tyrosine 332 is necessary for the caspase 3-dependent cleavage of PKCδ and the regulation of cell apoptosis,” Cellular Signalling, vol. 19, no. 10, pp. 2165–2173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  229. W. Lu, S. Finnis, C. Xiang et al., “Tyrosine 311 is phosphorylated by c-Abl and promotes the apoptotic effect of PKCδ in glioma cells,” Biochemical and Biophysical Research Communications, vol. 352, no. 2, pp. 431–436, 2007. View at Publisher · View at Google Scholar · View at Scopus
  230. R. Gomel, C. Xiang, S. Finniss et al., “The localization of protein kinase Cδ in different subcellular sites affects its proapoptotic and antiapoptotic functions and the activation of distinct downstream signaling pathways,” Molecular Cancer Research, vol. 5, no. 6, pp. 627–639, 2007. View at Publisher · View at Google Scholar · View at Scopus
  231. H. Okhrimenko, W. Lu, C. Xiang et al., “Roles of tyrosine phosphorylation and cleavage of protein kinase Cδ in its protective effect against tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis,” The Journal of Biological Chemistry, vol. 280, no. 25, pp. 23643–23652, 2005. View at Publisher · View at Google Scholar · View at Scopus
  232. A. Zrachia, M. Dobroslav, M. Blass et al., “Infection of glioma cells with Sindbis virus induces selective activation and tyrosine phosphorylation of protein kinase C δ: implications for sindbis virus-induced apoptosis,” The Journal of Biological Chemistry, vol. 277, no. 26, pp. 23693–23701, 2002. View at Publisher · View at Google Scholar · View at Scopus
  233. M. Blass, I. Kronfeld, G. Kazimirsky, P. M. Blumberg, and C. Brodie, “Tyrosine phosphorylation of protein kinase Cδ is essential for its apoptotic effect in response to etoposide,” Molecular and Cellular Biology, vol. 22, no. 1, pp. 182–195, 2002. View at Publisher · View at Google Scholar · View at Scopus
  234. R. Mandil, E. Ashkenazi, M. Blass et al., “Protein kinase Cα and protein kinase Cδ play opposite roles in the proliferation and apoptosis of glioma cells,” Cancer Research, vol. 61, no. 11, pp. 4612–4619, 2001. View at Google Scholar · View at Scopus
  235. S. L. Lomonaco, S. Kahana, M. Blass et al., “Phosphorylation of protein kinase Cδ on distinct tyrosine residues induces sustained activation of Erk1/2 via down-regulation of MKP-1: role in the apoptotic effect of etoposide,” The Journal of Biological Chemistry, vol. 283, no. 25, pp. 17731–17739, 2008. View at Publisher · View at Google Scholar · View at Scopus
  236. C. Peng, T. Tseng, J. Liu et al., “Penta-acetyl geniposide-induced C6 glioma cell apoptosis was associated with the activation of protein kinase C-delta,” Chemico-Biological Interactions, vol. 147, no. 3, pp. 287–296, 2004. View at Publisher · View at Google Scholar · View at Scopus
  237. C. Peng, C. Huang, S. Hsu, and C. Wang, “Penta-acetyl geniposide induce apoptosis in C6 glioma cells by modulating the activation of neutral sphingomyelinase-induced p75 nerve growth factor receptor and protein kinase Cδ pathway,” Molecular Pharmacology, vol. 70, no. 3, pp. 997–1004, 2006. View at Publisher · View at Google Scholar · View at Scopus
  238. S. Kim, J. Hwang, W. Lee, D. Y. Hwang, and K. Suk, “Role of protein kinase Cδ in paraquat-induced glial cell death,” Journal of Neuroscience Research, vol. 86, no. 9, pp. 2062–2070, 2008. View at Publisher · View at Google Scholar · View at Scopus
  239. M. Kim, R. Kim, C. Yoon et al., “Importance of PKCδ signaling in fractionatedradiation-induced expansion of glioma-initiating cells and resistance to cancer treatment,” Journal of Cell Science, vol. 124, no. 18, pp. 3084–3094, 2011. View at Publisher · View at Google Scholar · View at Scopus
  240. S. Amos, P. M. Martin, G. A. Polar, S. J. Parsons, and I. M. Hussaini, “Phorbol 12-myristate 13-acetate induces epidermal growth factor receptor transactivation via protein kinase Cδ/c-Src pathways in glioblastoma cells,” The Journal of Biological Chemistry, vol. 280, no. 9, pp. 7729–7738, 2005. View at Publisher · View at Google Scholar · View at Scopus
  241. B. S. Paugh, S. W. Paugh, L. Bryan et al., “EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCδ, and sphingosine kinase 1 in glioblastoma cells,” The FASEB Journal, vol. 22, no. 2, pp. 455–465, 2008. View at Publisher · View at Google Scholar · View at Scopus
  242. S. Sarkar and V. W. Yong, “Reduction of protein kinase C delta attenuates tenascin-C stimulated glioma invasion in three-dimensional matrix,” Carcinogenesis, vol. 31, no. 2, pp. 311–317, 2010. View at Publisher · View at Google Scholar · View at Scopus
  243. A. Forastiere, W. Koch, A. Trotti, and D. Sidransky, “Head and neck cancer,” The New England Journal of Medicine, vol. 345, no. 26, pp. 1890–1900, 2001. View at Google Scholar · View at Scopus
  244. R. I. Haddad and D. M. Shin, “Recent advances in head and neck cancer,” The New England Journal of Medicine, vol. 359, no. 11, pp. 1096–1154, 2008. View at Publisher · View at Google Scholar · View at Scopus
  245. E. E. W. Cohen, H. Zhu, M. W. Lingen et al., “A feed-forward loop involving protein kinase Cα and microRNAs regulates tumor cell cycle,” Cancer Research, vol. 69, no. 1, pp. 65–74, 2009. View at Publisher · View at Google Scholar · View at Scopus
  246. F. Liu, Z. Zhao, P. Li et al., “NF-κB participates in chemokine receptor 7-mediated cell survival in metastatic squamous cell carcinoma of the head and neck,” Oncology Reports, vol. 25, no. 2, pp. 383–391, 2011. View at Publisher · View at Google Scholar · View at Scopus
  247. Z. J. Zhao, P. Li, F. Y. Liu, L. Sun, and C. F. Sun, “PKCα take part in CCR7/NF-κB autocrine signaling loop in CCR7-positive squamous cell carcinoma of head and neck,” Molecular and Cellular Biochemistry, vol. 357, no. 1-2, pp. 181–187, 2011. View at Google Scholar · View at Scopus
  248. Q. Pan, L. W. Bao, T. N. Teknos, and S. D. Merajver, “Targeted disruption of protein kinase Cε reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma,” Cancer Research, vol. 66, no. 19, pp. 9379–9384, 2006. View at Publisher · View at Google Scholar · View at Scopus
  249. J. Datta, A. Smith, J. C. Lang et al., “microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Ce{open},” Oncogene, vol. 31, no. 36, pp. 4045–4053, 2012. View at Publisher · View at Google Scholar · View at Scopus
  250. E. E. W. Cohen, M. W. Lingen, B. Zhu et al., “Protein kinase Cζ mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase,” Cancer Research, vol. 66, no. 12, pp. 6296–6303, 2006. View at Publisher · View at Google Scholar · View at Scopus
  251. C. Valkova, C. Mertens, S. Weisheit, D. Imhof, and C. Liebmann, “Activation by tyrosine phosphorylation as a prerequisite for protein kinase Cζ to mediate epidermal growth factor receptor signaling to ERK,” Molecular Cancer Research, vol. 8, no. 5, pp. 783–797, 2010. View at Publisher · View at Google Scholar · View at Scopus
  252. Z. Xie, Y. Jiang, E. Liao et al., “PIKE mediates EGFR proliferative signaling in squamous cell carcinoma cells,” Oncogene, vol. 31, no. 49, pp. 5090–5098, 2012. View at Publisher · View at Google Scholar · View at Scopus
  253. K. C. Lai, C. J. Liu, K. W. Chang, and T. C. Lee, “Depleting IFIT2 mediates atypical PKC signaling to enhance the migration and metastatic activity of oral squamous cell carcinoma cells,” Oncogene, vol. 32, no. 32, pp. 3686–3697, 2013. View at Google Scholar
  254. C.-C. Yu, S.-C. Lo, and T.-C. V. Wang, “Telomerase is regulated by protein kinase C-ζ in human nasopharyngeal cancer cells,” Biochemical Journal, vol. 355, no. 2, pp. 459–464, 2001. View at Publisher · View at Google Scholar · View at Scopus
  255. M. J. Frederick, A. J. VanMeter, M. A. Gadhikar et al., “Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples,” American Journal of Pathology, vol. 178, no. 2, pp. 548–571, 2011. View at Publisher · View at Google Scholar · View at Scopus
  256. Y. Yang, J. Chu, M. Luo et al., “Amplification of PRKCI, located in 3q26, is associated with lymph node metastasis in esophageal squamous cell carcinoma,” Genes Chromosomes and Cancer, vol. 47, no. 2, pp. 127–136, 2008. View at Publisher · View at Google Scholar · View at Scopus
  257. S. Liu, B. Wang, Y. Jiang et al., “Atypical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to anoikis via PKCι-SKP2-AKT Pathway,” Molecular Cancer Research, vol. 9, no. 4, pp. 390–402, 2011. View at Publisher · View at Google Scholar · View at Scopus
  258. B. S. Wang, Y. Yang, H. Yang et al., “PKCι counteracts oxidative stress by regulating Hsc70 in an esophageal cancer cell line,” Cell Stress and Chaperones, vol. 18, no. 3, pp. 359–366, 2013. View at Google Scholar
  259. P. Chu, N. C. Hsu, H. Tai et al., “High nuclear protein kinase Cθ expression may correlate with disease recurrence and poor survival in oral squamous cell carcinoma,” Human Pathology, vol. 43, no. 2, pp. 276–281, 2012. View at Publisher · View at Google Scholar · View at Scopus
  260. P. Y. Chu, N. C. H. Hsu, S. H. Lin, M. F. How, and K. T. Yeh, “High nuclear protein kinase C βII expression is a marker of disease recurrence in oral squamous cell carcinoma,” Anticancer Research, vol. 32, no. 9, pp. 3987–3991, 2012. View at Google Scholar
  261. L. Ducher, F. Croquet, S. Gil, J. Davy, J. Féger, and A. Bréhier, “Differential expression of five protein kinase C isoenzymes in FAO and HepG2 hepatoma cell lines compared with normal rat hepatocytes,” Biochemical and Biophysical Research Communications, vol. 217, no. 2, pp. 546–553, 1995. View at Publisher · View at Google Scholar · View at Scopus
  262. S. Hsu, Y. Chou, S. Yin, and J. Liu, “Differential effects of phorbol ester on growth and protein kinase C isoenzyme regulation in human hepatoma Hep3B cells,” Biochemical Journal, vol. 333, part 1, pp. 57–64, 1998. View at Google Scholar · View at Scopus
  263. T. Ohigashi, C. S. Mallia, E. McGary et al., “Protein kinase C α protein expression is necessary for sustained erythropoietin production in human hepatocellular carcinoma (Hep3B) cells exposed to hypoxia,” Biochimica et Biophysica Acta, vol. 1450, no. 2, pp. 109–118, 1999. View at Publisher · View at Google Scholar · View at Scopus
  264. H. Lu, F. Chou, K. Yeh, Y. Chang, N. C. Hsu, and J. Chang, “Expression of protein kinase C family in human hepatocellular carcinoma,” Pathology and Oncology Research, vol. 16, no. 3, pp. 385–391, 2010. View at Publisher · View at Google Scholar · View at Scopus
  265. J. Wang, Q. Li, G. Du, J. Lu, and S. Zou, “Significance and expression of atypical protein kinase C-ι in human hepatocellular carcinoma,” Journal of Surgical Research, vol. 154, no. 1, pp. 143–149, 2009. View at Publisher · View at Google Scholar · View at Scopus
  266. G. Du, J. Wang, J. Lu et al., “Expression of P-aPKC-ι, E-cadherin, and β-catenin related to invasion and metastasis in hepatocellular carcinoma,” Annals of Surgical Oncology, vol. 16, no. 6, pp. 1578–1586, 2009. View at Publisher · View at Google Scholar · View at Scopus
  267. H. Lu, F. Chou, K. Yeh, Y. Chang, N. C. Hsu, and J. Chang, “Analysing the expression of protein kinase C eta in human hepatocellular carcinoma,” Pathology, vol. 41, no. 7, pp. 626–629, 2009. View at Publisher · View at Google Scholar · View at Scopus
  268. T. Wu, Y. Hsieh, Y. Hsieh, and J. Liu, “Reduction of PKCα decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma,” Journal of Cellular Biochemistry, vol. 103, no. 1, pp. 9–20, 2008. View at Publisher · View at Google Scholar · View at Scopus
  269. Y. Hsieh, T. Wu, C. Huang, Y. Hsieh, J. Hwang, and J. Liu, “p38 mitogen-activated protein kinase pathway is involved in protein kinase Cα-regulated invasion in human hepatocellular carcinoma cells,” Cancer Research, vol. 67, no. 9, pp. 4320–4327, 2007. View at Publisher · View at Google Scholar · View at Scopus
  270. J. Tsai, Y. Hsieh, S. Kuo et al., “Alteration in the expression of protein kinase C isoforms in human hepatocellular carcinoma,” Cancer Letters, vol. 161, no. 2, pp. 171–175, 2000. View at Publisher · View at Google Scholar · View at Scopus
  271. W. Wu, R. K. Tsai, C. H. Chang, S. Wang, J. Wu, and Y. Chang, “Reactive oxygen species mediated sustained activation of protein kinase C α and extracellular signal-regulated kinase for migration of human hepatoma cell Hepg2,” Molecular Cancer Research, vol. 4, no. 10, pp. 747–758, 2006. View at Publisher · View at Google Scholar · View at Scopus
  272. W. S. Wu, “Protein kinase C α trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2,” Cancer Letters, vol. 239, no. 1, pp. 27–35, 2006. View at Publisher · View at Google Scholar · View at Scopus
  273. W. S. Wu and J. M. Huang, “Activation of protein kinase C alpha is required for TPA-triggered ERK (MAPK) signaling and growth inhibition of human hepatoma cell HepG2,” Journal of Biomedical Science, vol. 12, no. 2, pp. 289–296, 2005. View at Publisher · View at Google Scholar · View at Scopus
  274. C. Chiang, Y. Huang, K. Leong et al., “PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells,” Journal of Biomedical Science, vol. 17, article 35, 2010. View at Publisher · View at Google Scholar · View at Scopus
  275. H. F. Bunn, “Erythropoietin,” Cold Spring Harbor Perspectives in Medicine, vol. 3, no. 3, Article ID a011619, 2013. View at Google Scholar
  276. C. T. Hu, C. C. Cheng, S. M. Pan, J. R. Wu, and W. S. Wu, “PKC mediates fluctuant ERK-paxillin signaling for hepatocyte growth factor-induced migration of hepatoma cell HepG2,” Cellular Signalling, vol. 25, no. 6, pp. 1457–1467, 2013. View at Google Scholar
  277. T. Wu, Y. Hsieh, C. Wu, Y. Hsieh, C. Huang, and J. Liu, “Overexpression of protein kinase Cα mRNA in human hepatocellular carcinoma: a potential marker of disease prognosis,” Clinica Chimica Acta, vol. 382, no. 1-2, pp. 54–58, 2007. View at Publisher · View at Google Scholar · View at Scopus
  278. C. Seeger and W. S. Mason, “Hepatitis B virus biology,” Microbiology and Molecular Biology Reviews, vol. 64, no. 1, pp. 51–68, 2000. View at Google Scholar · View at Scopus
  279. E. Hildt, B. Munz, G. Saher, K. Reifenberg, and P. H. Hofschneider, “The PreS2 activator MHBst of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice,” The EMBO Journal, vol. 21, no. 4, pp. 525–535, 2002. View at Publisher · View at Google Scholar · View at Scopus
  280. H. Liu, J. Xu, L. Zhou et al., “Hepatitis B virus large surface antigen promotes liver carcinogenesis by activating the Src/PI3K/Akt pathway,” Cancer Research, vol. 71, no. 24, pp. 7547–7557, 2011. View at Publisher · View at Google Scholar · View at Scopus
  281. J. Hung, Y. Lu, Y. Wang et al., “FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C δ signaling,” Cancer Research, vol. 68, no. 4, pp. 1204–1212, 2008. View at Publisher · View at Google Scholar · View at Scopus
  282. C. Yoon, M. Kim, M. Park et al., “Claudin-1 acts through c-Abl-protein kinase Cδ (PKCδ) signaling and has a causal role in the acquisition of invasive capacity in human liver cells,” The Journal of Biological Chemistry, vol. 285, no. 1, pp. 226–233, 2010. View at Publisher · View at Google Scholar · View at Scopus
  283. S. Takai, R. Matsushima-Nishiwaki, H. Tokuda et al., “Protein kinase C δ regulates the phosphorylation of heat shock protein 27 in human hepatocellular carcinoma,” Life Sciences, vol. 81, no. 7, pp. 585–591, 2007. View at Publisher · View at Google Scholar · View at Scopus
  284. K. Guo, N. X. Kang, Y. Li et al., “Regulation of HSP27 on NF-κB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis,” BMC Cancer, vol. 9, article 100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  285. Y. Wang, D. Sun, and D. Liu, “Tumor suppression by RNA from C/EBPβ 3′UTR through the inhibition of protein kinase Cε activity,” PLoS ONE, vol. 6, no. 1, Article ID e16543, 2011. View at Publisher · View at Google Scholar · View at Scopus
  286. K. Guo, Y. Li, X. Kang et al., “Role of PKCβ in hepatocellular carcinoma cells migration and invasion in vitro: a potential therapeutic target,” Clinical and Experimental Metastasis, vol. 26, no. 3, pp. 189–195, 2009. View at Publisher · View at Google Scholar · View at Scopus
  287. R. S. Herbst, J. V. Heymach, and S. M. Lippman, “Molecular origins of cancer: lung cancer,” The New England Journal of Medicine, vol. 359, no. 13, pp. 1367–1380, 2008. View at Publisher · View at Google Scholar · View at Scopus
  288. S. S. Singhal, S. Yadav, J. Singhal, K. Drake, Y. C. Awasthi, and S. Awasthi, “The role of PKCα and RLIP76 in transport-mediated doxorubicin-resistance in lung cancer,” FEBS Letters, vol. 579, no. 21, pp. 4635–4641, 2005. View at Publisher · View at Google Scholar · View at Scopus
  289. W. Lang, H. Wang, L. Ding, and L. Xiao, “Cooperation between PKC-α and PKC-ε in the regulation of JNK activation in human lung cancer cells,” Cellular Signalling, vol. 16, no. 4, pp. 457–467, 2004. View at Publisher · View at Google Scholar · View at Scopus
  290. M. Lahn, C. Su, S. Li et al., “Expression levels of protein kinase C-α in non-small-cell lung cancer,” Clinical Lung Cancer, vol. 6, no. 3, pp. 184–189, 2004. View at Google Scholar · View at Scopus
  291. A. K. O'Neill, L. L. Gallegos, V. Justilien et al., “Protein kinase Cα promotes cell migration through a PDZ-dependent interaction with its novel substrate discs large homolog 1 (DLG1),” The Journal of Biological Chemistry, vol. 286, no. 50, pp. 43559–43568, 2011. View at Publisher · View at Google Scholar · View at Scopus
  292. C. A. M. la Porta, L. Tessitore, and R. Comolli, “Changes in protein kinase C α,δ and in nuclear β isoform expression in tumour and lung metastatic nodules induced by diethylnitrosamine in the rat,” Carcinogenesis, vol. 18, no. 4, pp. 715–719, 1997. View at Publisher · View at Google Scholar · View at Scopus
  293. C. Wang, X. Wang, H. Liang et al., “miR-203 inhibits cell proliferation and migration lung cancer cells by targeting PKCα,” PLoS ONE, vol. 8, no. 9, Article ID e73985, 2013. View at Google Scholar
  294. D. Xiao, K. Wang, J. Zhou et al., “Inhibition of fibroblast growth factor 2-induced apoptosis involves survivin expression, protein kinase Cα activation and subcellular translocation of Smac in human small cell lung cancer cells,” Acta Biochimica et Biophysica Sinica, vol. 40, no. 4, pp. 297–303, 2008. View at Publisher · View at Google Scholar · View at Scopus
  295. K. S. Hill, E. Erdogan, A. Khoor et al., “Protein kinase Cα suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGFβ signaling axis,” Oncogene, 2013. View at Publisher · View at Google Scholar
  296. L. Paz-Ares, J. Douillard, P. Koralewski et al., “Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 24, no. 9, pp. 1428–1434, 2006. View at Publisher · View at Google Scholar · View at Scopus
  297. P. Ritch, C. M. Rudin, J. D. Bitran et al., “Phase II study of PKC-α antisense oligonucleotide aprinocarsen in combination with gemcitabine and carboplatin in patients with advanced non-small cell lung cancer,” Lung Cancer, vol. 52, no. 2, pp. 173–180, 2006. View at Publisher · View at Google Scholar · View at Scopus
  298. M. A. Villalona-Calero, P. Ritch, J. A. Figueroa et al., “A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-α, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer,” Clinical Cancer Research, vol. 10, no. 18, part 1, pp. 6086–6093, 2004. View at Publisher · View at Google Scholar · View at Scopus
  299. K. Bae, H. Wang, G. Jiang, M. G. Chen, L. Lu, and L. Xiao, “Protein kinase Cε is overexpressed in primary human non-small cell lung cancers and functionally required for proliferation of non-small cell lung cancer cells in a p21/Cip1-dependent manner,” Cancer Research, vol. 67, no. 13, pp. 6053–6063, 2007. View at Publisher · View at Google Scholar · View at Scopus
  300. M. C. Caino, C. Lopez-Haber, J. Kim, D. Mochly-Rosen, and M. G. Kazanietz, “Protein kinase Cɛ is required for non-small cell lung carcinoma growth and regulates the expression of apoptotic genes,” Oncogene, vol. 31, no. 20, pp. 2593–2600, 2012. View at Google Scholar
  301. M. Felber, J. Sonnemann, and J. F. Beck, “Inhibition of novel protein kinase Cε augments TRAIL-induced cell death in A549 lung cancer cells,” Pathology and Oncology Research, vol. 13, no. 4, pp. 295–301, 2007. View at Google Scholar · View at Scopus
  302. L. Ding, H. Wang, W. Lang, and L. Xiao, “Protein kinase C-ε promotes survival of lung cancer cells by suppressing apoptosis through dysregulation of the mitochondrial caspase pathway,” The Journal of Biological Chemistry, vol. 277, no. 38, pp. 35305–35313, 2002. View at Publisher · View at Google Scholar · View at Scopus
  303. O. E. Pardo, C. Wellbrock, U. K. Khanzada et al., “FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCε, B-Raf and S6K2,” The EMBO Journal, vol. 25, no. 13, pp. 3078–3088, 2006. View at Publisher · View at Google Scholar · View at Scopus
  304. M. C. Caino, C. Lopez-Haber, J. L. Kissil, and M. G. Kazanietz, “Non-small cell lung carcinoma cell motility, Rac activation and metastatic dissemination are mediated by protein kinase C epsilon,” PLoS ONE, vol. 7, no. 2, Article ID e31714, 2012. View at Publisher · View at Google Scholar · View at Scopus
  305. S. Tuomi, A. Mai, J. Nevo et al., “PKCε regulation of an α5 integrin-ZO-1 complex controls lamellae formation in migrating cancer cells,” Science Signaling, vol. 2, no. 77, article ra32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  306. R. P. Regala, C. Weems, L. Jamieson et al., “Atypical protein kinase Cι is an oncogene in human non-small cell lung cancer,” Cancer Research, vol. 65, no. 19, pp. 8905–8911, 2005. View at Publisher · View at Google Scholar · View at Scopus
  307. R. P. Regala, C. Weems, L. Jamieson, J. A. Copland, E. A. Thompson, and A. P. Fields, “Atypical protein kinase Cτ plays a critical role in human lung cancer cell growth and tumorigenicity,” The Journal of Biological Chemistry, vol. 280, no. 35, pp. 31109–31115, 2005. View at Publisher · View at Google Scholar · View at Scopus
  308. S. Liu, B. Wang, Y. Jiang et al., “Atypical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to anoikis via PKCι-SKP2-AKT pathway,” Molecular Cancer Research, vol. 9, no. 4, pp. 390–402, 2011. View at Publisher · View at Google Scholar · View at Scopus
  309. L. Xu and X. Deng, “Protein kinase Cι promotes nicotine-induced migration and invasion of cancer cells via phosphorylation of μ- and m-calpains,” The Journal of Biological Chemistry, vol. 281, no. 7, pp. 4457–4466, 2006. View at Publisher · View at Google Scholar · View at Scopus
  310. J. C. Shultz, N. Vu, M. D. Shultz, M. U. U. Mba, B. A. Shapiro, and C. E. Chalfant, “The proto-oncogene PKCι regulates the alternative splicing of Bcl-x pre-mRNA,” Molecular Cancer Research, vol. 10, no. 5, pp. 660–669, 2012. View at Publisher · View at Google Scholar
  311. R. P. Regala, E. A. Thompson, and A. P. Fields, “Atypical protein kinase Cι expression and aurothiomalate sensitivity in human lung cancer cells,” Cancer Research, vol. 68, no. 14, pp. 5888–5895, 2008. View at Publisher · View at Google Scholar · View at Scopus
  312. V. Justilien, L. Jameison, C. J. Der, K. L. Rossman, and A. P. Fields, “Oncogenic activity of Ect2 is regulated through protein kinase Cι-mediated phosphorylation,” The Journal of Biological Chemistry, vol. 286, no. 10, pp. 8149–8157, 2011. View at Publisher · View at Google Scholar · View at Scopus
  313. L. A. Frederick, J. A. Matthews, L. Jamieson et al., “Matrix metalloproteinase-10 is a critical effector of protein kinase Cι-Par6α-mediated lung cancer,” Oncogene, vol. 27, no. 35, pp. 4841–4853, 2008. View at Publisher · View at Google Scholar · View at Scopus
  314. E. Erdogan, E. W. Klee, E. A. Thompson, and A. P. Fields, “Meta-analysis of oncogenic protein kinase Cι signaling in lung adenocarcinoma,” Clinical Cancer Research, vol. 15, no. 5, pp. 1527–1533, 2009. View at Publisher · View at Google Scholar · View at Scopus
  315. D. Meng, M. Yuan, X. Li et al., “Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: a systematic review with meta-analysis,” Lung Cancer, vol. 81, no. 1, pp. 1–10, 2013. View at Publisher · View at Google Scholar
  316. N. Karachaliou, C. Mayo, C. Costa et al., “KRAS mutations in lung cancer,” Clinical Lung Cancer, vol. 14, no. 3, pp. 205–214, 2013. View at Publisher · View at Google Scholar
  317. M. Stailings-Mann, L. Jamieson, R. P. Regala, C. Weems, N. R. Murray, and A. P. Fields, “A novel small-molecule inhibitor of protein kinase Cι blocks transformed growth of non-small-cell lung cancer cells,” Cancer Research, vol. 66, no. 3, pp. 1767–1774, 2006. View at Publisher · View at Google Scholar · View at Scopus
  318. R. P. Regala, R. K. Davis, A. Kunz, A. Khoor, M. Leitges, and A. P. Fields, “Atypical protein kinase Cι is required for bronchioalveolar stem cell expansion and lung tumorigenesis,” Cancer Research, vol. 69, no. 19, pp. 7603–7611, 2009. View at Publisher · View at Google Scholar · View at Scopus
  319. W. Guo, S. Wu, J. Liu, and B. Fang, “Identification of a small molecule with synthetic lethality for K-Ras and protein kinase C iota,” Cancer Research, vol. 68, no. 18, pp. 7403–7408, 2008. View at Publisher · View at Google Scholar · View at Scopus
  320. E. Krasnitsky, Y. Baumfeld, J. Freedman et al., “PKCη is a novel prognostic marker in non-small cell lung cancer,” Anticancer Research, vol. 32, no. 4, pp. 1507–1513, 2012. View at Google Scholar · View at Scopus
  321. J. Sonnemann, V. Gekeler, K. Ahlbrecht et al., “Down-regulation of protein kinase Cη by antisense oligonucleotides sensitises A549 lung cancer cells to vincristine and paclitaxel,” Cancer Letters, vol. 209, no. 2, pp. 177–185, 2004. View at Publisher · View at Google Scholar · View at Scopus
  322. Y. Liu, B. Wang, J. Wang et al., “Down-regulation of PKCζ expression inhibits chemotaxis signal transduction in human lung cancer cells,” Lung Cancer, vol. 63, no. 2, pp. 210–218, 2009. View at Publisher · View at Google Scholar · View at Scopus
  323. J. M. Symonds, A. M. Ohm, C. J. Carter et al., “Protein kinase C δ is a downstream effector of oncogenic K-ras in lung tumors,” Cancer Research, vol. 71, no. 6, pp. 2087–2097, 2011. View at Publisher · View at Google Scholar · View at Scopus
  324. A. S. Clark, K. A. West, P. M. Blumberg, and P. A. Dennis, “Altered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKCδ promotes cellular survival and chemotherapeutic resistance,” Cancer Research, vol. 63, no. 4, pp. 780–786, 2003. View at Google Scholar · View at Scopus
  325. E. Kim, H. Lee, D. Lee et al., “Inhibition of heat shock protein 27-mediated resistance to DNA damaging agents by a novel PKCδ-V5 heptapeptide,” Cancer Research, vol. 67, no. 13, pp. 6333–6341, 2007. View at Publisher · View at Google Scholar · View at Scopus
  326. L. Xu, L. Su, and X. Liu, “PKCδ regulates death receptor 5 expression induced by PS-341 through ATF4-ATF3/CHOP axis in human lung cancer cells,” Molecular Cancer Therapeutics, vol. 11, no. 10, pp. 2174–2182, 2012. View at Google Scholar
  327. M. Nakagawa, J. L. Oliva, D. Kothapalli, A. Fournier, R. K. Assoian, and M. G. Kazanietz, “Phorbol ester-induced G1 phase arrest selectively mediated by protein kinase Cδ-dependent induction of p21,” The Journal of Biological Chemistry, vol. 280, no. 40, pp. 33926–33934, 2005. View at Publisher · View at Google Scholar · View at Scopus
  328. S. S. Hecht, “Tobacco carcinogens, their biomarkers and tobacco-induced cancer,” Nature Reviews Cancer, vol. 3, no. 10, pp. 733–744, 2003. View at Google Scholar · View at Scopus
  329. H. Lemjabbar-Alaoui, S. S. Sidhu, A. Mengistab, M. Gallup, and C. Basbaum, “TACE/ADAM-17 phosphorylation by PKC-epsilon mediates premalignant changes in Tobacco smoke-exposed lung cells,” PLoS ONE, vol. 6, no. 3, Article ID e17489, 2011. View at Publisher · View at Google Scholar · View at Scopus
  330. Y. M. Whang, U. Jo, J. S. Sung et al., “Wnt5a is associated with cigarette smoke-related lung carcinogenesis via protein kinase C,” PLoS ONE, vol. 8, no. 1, Article ID e53012, 2013. View at Publisher · View at Google Scholar
  331. J. Shen, L. Xu, T. K. Owonikoko et al., “NNK promotes migration and invasion of lung cancer cells through activation of c-Src/PKCι/FAK loop,” Cancer Letters, vol. 318, no. 1, pp. 106–113, 2012. View at Publisher · View at Google Scholar · View at Scopus
  332. R. Gopalakrishna, Z. Chen, and U. Gundimeda, “Tobacco smoke tumor promoters, catechol and hydroquinone, induce oxidative regulation of protein kinase C and influence invasion and metastasis of lung carcinoma cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 25, pp. 12233–12237, 1994. View at Publisher · View at Google Scholar · View at Scopus
  333. M. Oka and U. Kikkawa, “Protein kinase C in melanoma,” Cancer and Metastasis Reviews, vol. 24, no. 2, pp. 287–300, 2005. View at Publisher · View at Google Scholar · View at Scopus
  334. M. F. Denning, “Specifying protein kinase C functions in melanoma,” Pigment Cell & Melanoma Research, vol. 25, no. 4, pp. 466–476, 2012. View at Google Scholar
  335. M. M. Lahn and K. L. Sundell, “The role of protein kinase C-alpha (PKC-α) in melanoma,” Melanoma Research, vol. 14, no. 2, pp. 85–89, 2004. View at Publisher · View at Google Scholar · View at Scopus
  336. S. D. Smith, M. Enge, W. Bao et al., “Protein kinase Cα (PKCα) regulates p53 localization and melanoma cell survival downstream of integrin αv in three-dimensional collagen and in vivo,” The Journal of Biological Chemistry, vol. 287, no. 35, pp. 29336–29347, 2012. View at Publisher · View at Google Scholar
  337. A. J. Putnam, V. V. Schulz, E. M. Freiter, H. M. Bill, and C. K. Miranti, “Src, PKCα, and PKCδ are required for αvβ3 integrin-mediated metastatic melanoma invasion,” Cell Communication and Signalling, vol. 7, article 10, 2009. View at Publisher · View at Google Scholar
  338. H. R. Byers, S. J. S. Boissel, C. Tu, and H. Park, “RNAi-mediated knockdown of protein kinase C-alpha inhibits cell migration in MM-RU human metastatic melanoma cell line,” Melanoma Research, vol. 20, no. 3, pp. 171–178, 2010. View at Publisher · View at Google Scholar · View at Scopus
  339. A. Vartanian, E. Stepanova, I. Grigorieva, E. Solomko, A. Baryshnikov, and M. Lichinitser, “VEGFR1 and PKCα signaling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner,” Melanoma Research, vol. 21, no. 2, pp. 91–98, 2011. View at Publisher · View at Google Scholar · View at Scopus
  340. R. E. B. Seftor, A. R. Hess, E. A. Seftor et al., “Tumor cell vasculogenic mimicry: from controversy to therapeutic promise,” The American Journal of Pathology, vol. 181, no. 4, pp. 1115–1125, 2012. View at Publisher · View at Google Scholar
  341. J. H. Kang, D. Asai, J. Oishi et al., “Role of plasma as activator and cofactor in phosphorylation catalyzed by protein kinase C,” Cell Biochemistry and Function, vol. 26, no. 1, pp. 70–75, 2008. View at Publisher · View at Google Scholar · View at Scopus
  342. S. Gillespie, X. D. Zhang, and P. Hersey, “Variable expression of protein kinase Cε in human melanoma cells regulates sensitivity to TRAIL-induced apoptosis,” Molecular Cancer Therapeutics, vol. 4, no. 4, pp. 668–676, 2005. View at Publisher · View at Google Scholar · View at Scopus
  343. N. M. Mhaidat, R. F. Thorne, X. D. Zhang, and P. Hersey, “Regulation of docetaxel-induced apoptosis of human melanoma cells by different isoforms of protein kinase C,” Molecular Cancer Research, vol. 5, no. 10, pp. 1073–1081, 2007. View at Publisher · View at Google Scholar · View at Scopus
  344. E. Lau, H. Kluger, T. Varsano et al., “PKCε promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria,” Cell, vol. 148, no. 3, pp. 543–555, 2012. View at Publisher · View at Google Scholar · View at Scopus
  345. M. Oka, U. Kikkawa, and C. Nishigori, “Protein kinase C-βII represses hepatocyte growth factor-induced invasion by preventing the association of adapter protein Gab1 and phosphatidylinositol 3-kinase in melanoma cells,” Journal of Investigative Dermatology, vol. 128, no. 1, pp. 188–195, 2008. View at Publisher · View at Google Scholar · View at Scopus
  346. J. P. Voris, L. A. Sitailo, H. R. Rahn et al., “Functional alterations in protein kinase C beta II expression in melanoma,” Pigment Cell and Melanoma Research, vol. 23, no. 2, pp. 216–224, 2010. View at Publisher · View at Google Scholar · View at Scopus
  347. C. A. M. la Porta and R. Comolli, “Overexpression of nPKCδ in BL6 murine melanoma cells enhances TGFβ1 release into the plasma of metastasized animals,” Melanoma Research, vol. 10, no. 6, pp. 527–534, 2000. View at Publisher · View at Google Scholar · View at Scopus
  348. C. A. M. la Porta, A. di Dio, D. Porro, and R. Comolli, “Overexpression of novel protein kinase C δ in BL6 murine melanoma cells inhibits the proliferative capacity in vitro but enhances the metastatic potential in vivo,” Melanoma Research, vol. 10, no. 2, pp. 93–102, 2000. View at Google Scholar · View at Scopus
  349. E. Albi, C. A. M. la Porta, S. Cataldi, and M. V. Magni, “Nuclear sphingomyelin-synthase and protein kinase C δ in melanoma cells,” Archives of Biochemistry and Biophysics, vol. 438, no. 2, pp. 156–161, 2005. View at Publisher · View at Google Scholar · View at Scopus
  350. N. M. Mhaidat, R. F. Thorne, D. Z. Xu, and P. Hersey, “Regulation of docetaxel-induced apoptosis of human melanoma cells by different isoforms of protein kinase C,” Molecular Cancer Research, vol. 5, no. 10, pp. 1073–1081, 2007. View at Publisher · View at Google Scholar · View at Scopus
  351. S. T. Abrams, T. Lakum, K. Lin et al., “B-cell receptor signaling in chronic lymphocytic leukemia cells is regulated by overexpressed active protein kinase CβII,” Blood, vol. 109, no. 3, pp. 1193–1201, 2007. View at Publisher · View at Google Scholar · View at Scopus
  352. N. N. Kabir, L. Rönnstrand, and J. U. Kazi, “Protein kinase C expression is deregulated in chronic lymphocytic leukemia,” Leukemia & Lymphoma, vol. 54, no. 10, pp. 2288–2290, 2013. View at Google Scholar
  353. J. U. Kazi, N. N. Kabir, and L. Rönnstrand, “Protein kinase C, (PKC) as a drug target in chronic lymphocytic leukemia,” Medical Oncology, vol. 30, no. 4, article 757, 2013. View at Publisher · View at Google Scholar
  354. I. Espinosa, J. Briones, R. Bordes et al., “Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma,” Annals of Hematology, vol. 85, no. 9, pp. 597–603, 2006. View at Publisher · View at Google Scholar · View at Scopus
  355. R. Schaffel, J. C. Morais, I. Biasoli et al., “PKC-beta II expression has prognostic impact in nodal diffuse large B-cell lymphoma,” Modern Pathology, vol. 20, no. 3, pp. 326–330, 2007. View at Publisher · View at Google Scholar · View at Scopus
  356. S. Riihijärvi, S. Koivula, H. Nyman, K. Rydström, M. Jerkeman, and S. Leppä, “Prognostic impact of protein kinase C βII expression in R-CHOP-treated diffuse large B-cell lymphoma patients,” Modern Pathology, vol. 23, no. 5, pp. 686–693, 2010. View at Publisher · View at Google Scholar · View at Scopus
  357. N. S. Saba and L. S. Levy, “Apoptotic induction in B-cell acute lymphoblastic leukemia cell lines treated with a protein kinase Cβ inhibitor,” Leukemia & Lymphoma, vol. 52, no. 5, pp. 877–886, 2011. View at Publisher · View at Google Scholar · View at Scopus
  358. S. T. Abrams, B. R. B. Brown, M. Zuzel, and J. R. Slupsky, “Vascular endothelial growth factor stimulates protein kinase C βII expression in chronic lymphocytic leukemia cells,” Blood, vol. 115, no. 22, pp. 4447–4454, 2010. View at Publisher · View at Google Scholar · View at Scopus
  359. M. Barragán, M. de Frias, D. Iglesias-Serret et al., “Regulation of Akt/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells: role of protein kinase Cβ,” Journal of Leukocyte Biology, vol. 80, no. 6, pp. 1473–1479, 2006. View at Publisher · View at Google Scholar · View at Scopus
  360. C. Holler, J. D. Piñón, U. Denk et al., “PKCβ is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCβ as a therapeutic target in chronic lymphocytic leukemia,” Blood, vol. 113, no. 12, pp. 2791–2794, 2009. View at Publisher · View at Google Scholar · View at Scopus
  361. A. Patke, I. Mecklenbräuker, H. Erdjument-Bromage, P. Tempst, and A. Tarakhovsky, “BAFF controls B cell metabolic fitness through a PKCβ- and Akt-dependent mechanism,” Journal of Experimental Medicine, vol. 203, no. 11, pp. 2551–2562, 2006. View at Publisher · View at Google Scholar · View at Scopus
  362. C. M. zum Büschenfelde, M. Wagner, G. Lutzny et al., “Recruitment of PKC-βII to lipid rafts mediates apoptosis-resistance in chronic lymphocytic leukemia expressing ZAP-70,” Leukemia, vol. 24, no. 1, pp. 141–152, 2010. View at Publisher · View at Google Scholar · View at Scopus
  363. G. Lutzny, T. Kocher, M. Schmidt-Supprian et al., “Protein kinase C-β-dependent activation of NF-κB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in vivo,” Cancer Cell, vol. 23, no. 1, pp. 77–92, 2013. View at Publisher · View at Google Scholar
  364. I. Ringshausen, F. Schneller, C. Bogner et al., “Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cδ,” Blood, vol. 100, no. 10, pp. 3741–3748, 2002. View at Publisher · View at Google Scholar · View at Scopus
  365. A. D. Baudot, P. Y. Jeandel, X. Mouska et al., “The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKC and proteasome-dependent regulation of Mcl-1 expression,” Oncogene, vol. 28, no. 37, pp. 3261–3273, 2009. View at Publisher · View at Google Scholar · View at Scopus
  366. R. Hubmann, M. Düchler, S. Schnabl et al., “NOTCH2 links protein kinase C delta to the expression of CD23 in chronic lymphocytic leukaemia (CLL) cells: research paper,” British Journal of Haematology, vol. 148, no. 6, pp. 868–878, 2010. View at Publisher · View at Google Scholar · View at Scopus
  367. T. Jiffar, S. Kurinna, G. Suck et al., “PKC α mediates chemoresistance in acute lymphoblastic leukemia through effects on Bcl2 phosphorylation,” Leukemia, vol. 18, no. 3, pp. 505–512, 2004. View at Publisher · View at Google Scholar · View at Scopus
  368. N. R. Murray, G. P. Baumgardner, D. J. Burns, and A. P. Fields, “Protein kinase C isotypes in human erythroleukemia (K562) cell proliferation and differentiation. Evidence that β(II) protein kinase C is required for proliferation,” The Journal of Biological Chemistry, vol. 268, no. 21, pp. 15847–15853, 1993. View at Google Scholar · View at Scopus
  369. M. Kaneki, S. Kharbanda, P. Pandey et al., “Functional role for protein kinase Cβ as a regulator of stress- activated protein kinase activation and monocytic differentiation of myeloid leukemia cells,” Molecular and Cellular Biology, vol. 19, no. 1, pp. 461–470, 1999. View at Google Scholar · View at Scopus
  370. P. P. Ruvolo, L. Zhou, J. C. Watt et al., “Targeting PKC-mediated signal transduction pathways using enzastaurin to promote apoptosis in acute myeloid leukemia-derived cell lines and blast cells,” Journal of Cellular Biochemistry, vol. 112, no. 6, pp. 1696–1707, 2011. View at Publisher · View at Google Scholar · View at Scopus
  371. X. Li, Y. Li, Y. Zhang et al., “A novel bisindolymaleimide derivative (WK234) inhibits proliferation and induces apoptosis through the protein kinase Cβ pathway, in chronic myelogenous leukemia K562 cells,” Leukemia & Lymphoma, vol. 52, no. 7, pp. 1312–1320, 2011. View at Publisher · View at Google Scholar · View at Scopus
  372. F. Pellicano, M. Copland, H. G. Jorgensen, J. Mountford, B. Leber, and T. L. Holyoake, “BMS-214662 induces mitochondrial apoptosis in chronic myeloid leukemia (CML) stem/progenitor cells, including CD34+38 cells, through activation of protein kinase Cβ,” Blood, vol. 114, no. 19, pp. 4186–4196, 2009. View at Publisher · View at Google Scholar · View at Scopus
  373. A. Cataldi, M. Rapino, L. Centurione et al., “NF-κB activation plays an antiapoptotic role in human leukemic K562 cells exposed to ionizing radiation,” Journal of Cellular Biochemistry, vol. 89, no. 5, pp. 956–963, 2003. View at Publisher · View at Google Scholar · View at Scopus
  374. S. Kaur, S. Parmar, J. Smith et al., “Role of protein kinase C-δ (PKC-δ) in the generation of the effects of IFN-α in chronic myelogenous leukemia cells,” Experimental Hematology, vol. 33, no. 5, pp. 550–557, 2005. View at Publisher · View at Google Scholar · View at Scopus
  375. V. di Giacomo, M. Rapino, S. Miscia, C. di Giulio, and A. Cataldi, “Dual role of HIF-1α in delivering a survival or death signal in hypoxia exposed human K562 erythroleukemia cells,” Cell Biology International, vol. 33, no. 1, pp. 49–56, 2009. View at Publisher · View at Google Scholar · View at Scopus
  376. Z. Li, K. Shi, L. Guan, Q. Jiang, Y. Yang, and C. Xu, “Downregulation of protein kinase Cα was involved in selenite-induced apoptosis of NB4 cells,” Oncology Research, vol. 19, no. 2, pp. 77–83, 2010. View at Publisher · View at Google Scholar · View at Scopus
  377. S. Kurinna, M. Konopleva, S. L. Palla et al., “Bcl2 phosphorylation and active PKC α are associated with poor survival in AML,” Leukemia, vol. 20, no. 7, pp. 1316–1319, 2006. View at Publisher · View at Google Scholar · View at Scopus
  378. S. M. Kornblau, H. T. Vu, P. Ruvolo et al., “BAX and PKCα modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia,” Clinical Cancer Research, vol. 6, no. 4, pp. 1401–1409, 2000. View at Google Scholar · View at Scopus
  379. P. P. Ruvolo, X. Deng, B. K. Carr, and W. S. May, “A functional role for mitochondrial protein kinase Cα in Bcl2 phosphorylation and suppression of apoptosis,” The Journal of Biological Chemistry, vol. 273, no. 39, pp. 25436–25442, 1998. View at Publisher · View at Google Scholar · View at Scopus
  380. F. Gao, Y. Wu, M. Zhao, C. Liu, L. Wang, and G. Chen, “Protein kinase C-δ mediates down-regulation of heterogeneous nuclear ribonucleoprotein K protein: involvement in apoptosis induction,” Experimental Cell Research, vol. 315, no. 19, pp. 3250–3258, 2009. View at Publisher · View at Google Scholar · View at Scopus
  381. B. Ozpolat, U. Akar, I. Tekedereli et al., “PKCδ regulates translation initiation through PKR and eIF2α in response to retinoic acid in acute myeloid leukemia cells,” Leukemia Research and Treatment, vol. 2012, Article ID 482905, 17 pages, 2012. View at Publisher · View at Google Scholar
  382. S. Wang, Y. Zheng, Y. Yu et al., “Phosphorylation of β-actin by protein kinase C-delta in camptothecin analog-induced leukemic cell apoptosis,” Acta Pharmacologica Sinica, vol. 29, no. 1, pp. 135–142, 2008. View at Publisher · View at Google Scholar · View at Scopus
  383. H. Yan, Y.-C. Wang, D. Li et al., “Arsenic trioxide and proteasome inhibitor bortezomib synergistically induce apoptosis in leukemic cells: the role of protein kinase Cδ,” Leukemia, vol. 21, no. 7, pp. 1488–1495, 2007. View at Publisher · View at Google Scholar · View at Scopus
  384. M. Song, S. Gao, K. Du et al., “Nanomolar concentration of NSC606985, a camptothecin analog, induces leukemic-cell apoptosis through protein kinase Cδ-dependent mechanisms,” Blood, vol. 105, no. 9, pp. 3714–3721, 2005. View at Publisher · View at Google Scholar · View at Scopus
  385. B. Jang, K. Lim, J. Paik et al., “Tetrandrine-induced apoptosis is mediated by activation of caspases and PKC-δ in U937 cells,” Biochemical Pharmacology, vol. 67, no. 10, pp. 1819–1829, 2004. View at Publisher · View at Google Scholar · View at Scopus
  386. H. Zhang, Y. Yang, K. Zhang et al., “Wogonin induced differentiation and G1 phase arrest of human U-937 leukemia cells via PKCδ phosphorylation,” European Journal of Pharmacology, vol. 591, no. 1–3, pp. 7–12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  387. A. Sassano, J. K. Altman, L. I. Gordon, and L. C. Platanias, “Statin-dependent activation of protein kinase Cδ in acute promyelocytic leukemia cells and induction of leukemic cell differentiation,” Leukemia & Lymphoma, vol. 53, no. 9, pp. 1779–1784, 2012. View at Google Scholar
  388. A. Uruno, N. Noguchi, K. Matsuda et al., “All-trans retinoic acid and a novel synthetic retinoid tamibarotene (Am80) differentially regulate CD38 expression in human leukemia HL-60 cells: possible involvement of protein kinase C-δ,” Journal of Leukocyte Biology, vol. 90, no. 2, pp. 235–247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  389. K. Ohtani, H. Sakamoto, A. Kikuchi et al., “Follicle-stimulating hormone promotes the growth of human epithelial ovarian cancer cells through the protein kinase C-mediated system,” Cancer Letters, vol. 166, no. 2, pp. 207–213, 2001. View at Publisher · View at Google Scholar · View at Scopus
  390. C. Mahanivong, H. M. Chen, S. W. Yee, Z. K. Pan, Z. Dong, and S. Huang, “Protein kinase Cα-CARMA3 signaling axis links Ras to NF-κB for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells,” Oncogene, vol. 27, no. 9, pp. 1273–1280, 2008. View at Publisher · View at Google Scholar · View at Scopus
  391. W. Weichert, V. Gekeler, C. Denkert, M. Dietel, and S. Hauptmann, “Protein kinase C isoform expression in ovarian carcinoma correlates with indicator of poor prognosis,” International Journal of Oncology, vol. 23, no. 3, pp. 633–639, 2003. View at Google Scholar
  392. N. Zhang, H. Zhang, L. Xia et al., “NSC606985 induces apoptosis, exerts synergistic effects with cisplatin, and inhibits hypoxia-stabilized HIF-1α protein in human ovarian cancer cells,” Cancer Letters, vol. 278, no. 2, pp. 139–144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  393. A. M. Eder, X. Sui, D. G. Rosen et al., “Atypical PKCι contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 35, pp. 12519–12524, 2005. View at Publisher · View at Google Scholar · View at Scopus
  394. I. Nazarenko, M. Jenny, J. Keil et al., “Atypical protein kinase C ζ exhibits a proapoptotic function in ovarian cancer,” Molecular Cancer Research, vol. 8, no. 6, pp. 919–934, 2010. View at Publisher · View at Google Scholar · View at Scopus
  395. I. Mertens-Walker, C. Bolitho, R. C. Baxter, and D. J. Marsh, “Gonadotropin-induced ovarian cancer cell migration and proliferation require extracellular signal-regulated kinase 1/2 activation regulated by calcium and protein kinase Cδ,” Endocrine-Related Cancer, vol. 17, no. 2, pp. 335–349, 2010. View at Publisher · View at Google Scholar · View at Scopus
  396. J. Yang and R. A. Weinberg, “Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis,” Developmental Cell, vol. 14, no. 6, pp. 818–829, 2008. View at Publisher · View at Google Scholar · View at Scopus
  397. D. Kyuno, T. Kojima, T. Ito et al., “Protein kinase Cα inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens enterotoxin via claudin-4,” Cell and Tissue Research, vol. 346, no. 3, pp. 369–381, 2011. View at Publisher · View at Google Scholar · View at Scopus
  398. D. Kyuno, T. Kojima, H. Yamaguchi et al., “Protein kinase Cα inhibitor protects against downregulation of claudin-1 during epithelial-mesenchymal transition of pancreatic cancer,” Carcinogenesis, vol. 34, no. 6, pp. 1232–1243, 2013. View at Publisher · View at Google Scholar
  399. Y. Chen, G. Yu, D. Yu, and M. Zhu, “PKCα-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-β1,” Journal of Experimental and Clinical Cancer Research, vol. 29, no. 1, article 104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  400. J. Y. C. Chow, H. Dong, K. T. Quach, P. N. van Nguyen, K. Chen, and J. M. Carethers, “TGF-β mediates PTEN suppression and cell motility through calcium-dependent PKC-α activation in pancreatic cancer cells,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 294, no. 4, pp. G899–G905, 2008. View at Publisher · View at Google Scholar · View at Scopus
  401. M. G. Franz, J. G. Norman, P. J. Fabri, and W. R. Gower Jr., “Differentiation of pancreatic ductal carcinoma cells associated with selective expression of protein kinase C isoforms,” Annals of Surgical Oncology, vol. 3, no. 6, pp. 564–569, 1996. View at Google Scholar · View at Scopus
  402. S. Rosewicz, F. Brembeck, A. Kaiser, Z. V. Marschall, and E. Riecken, “Differential growth regulation by all-trans retinoic acid is determined by protein kinase C α in human pancreatic carcinoma cells,” Endocrinology, vol. 137, no. 8, pp. 3340–3347, 1996. View at Publisher · View at Google Scholar · View at Scopus
  403. D. W. Denham, M. G. Franz, W. Denham et al., “Directed antisense therapy confirms the role of protein kinase C-α in the tumorigenicity of pancreatic cancer,” Surgery, vol. 124, no. 2, pp. 218–224, 1998. View at Publisher · View at Google Scholar · View at Scopus
  404. K. M. Detjen, F. H. Brembeck, M. Welzel et al., “Activation of protein kinase Cα inhibits growth of pancreatic cancer cells via p21cip-mediated G1 arrest,” Journal of Cell Science, vol. 113, no. 17, pp. 3025–3035, 2000. View at Google Scholar · View at Scopus
  405. A. M. Butler, M. L. S. Buzhardt, S. Li, K. E. Smith, A. P. Fields, and N. R. Murray, “Protein kinase C zeta regulates human pancreatic cancer cell transformed growth and invasion through a STAT3-dependent mechanism,” PLoS ONE, vol. 8, no. 8, Article ID e72061, 2013. View at Publisher · View at Google Scholar
  406. C. Laudanna, C. Sorio, C. Tecchio et al., “Motility analysis of pancreatic adenocarcinoma cells reveals a role for the atypical ζ isoform of protein kinase C in cancer cell movement,” Laboratory Investigation, vol. 83, no. 8, pp. 1155–1163, 2003. View at Publisher · View at Google Scholar · View at Scopus
  407. M. D. Peruta, C. Giagulli, C. Laudanna, A. Scarpa, and C. Sorio, “RHOA and PRKCZ control different aspects of cell motility in pancreatic cancer metastatic clones,” Molecular Cancer, vol. 9, article 61, 2010. View at Publisher · View at Google Scholar · View at Scopus
  408. M. Neid, K. Datta, S. Stephan et al., “Role of insulin receptor substrates and protein kinase C-ζ in vascular permeability factor/vascular endothelial growth factor expression in pancreatic cancer cells,” The Journal of Biological Chemistry, vol. 279, no. 6, pp. 3941–3948, 2004. View at Publisher · View at Google Scholar · View at Scopus
  409. M. L. Scotti, W. R. Bamlet, T. C. Smyrk, A. P. Fields, and N. R. Murray, “Protein kinase Cι is required for pancreatic cancer cell transformed growth and tumorigenesis,” Cancer Research, vol. 70, no. 5, pp. 2064–2074, 2010. View at Publisher · View at Google Scholar · View at Scopus
  410. S. Kato, K. Akimoto, Y. Nagashima et al., “aPKCλ/ι is a beneficial prognostic marker for pancreatic neoplasms,” Pancreatology, vol. 13, no. 4, pp. 360–368, 2013. View at Publisher · View at Google Scholar
  411. M. L. Scotti, K. E. Smith, A. M. Butler et al., “Protein kinase C iota regulates pancreatic acinar-to-ductal metaplasia,” PLoS ONE, vol. 7, no. 2, Article ID e30509, 2012. View at Publisher · View at Google Scholar · View at Scopus
  412. S. M. Cirigliano, L. V. Mauro, V. C. Grossoni et al., “Modulation of pancreatic tumor potential by overexpression of protein kinase C β1,” Pancreas, vol. 42, no. 7, pp. 1060–1069, 2013. View at Publisher · View at Google Scholar
  413. A. C. Spalding, R. Watson, M. E. Davis, A. C. Kim, T. S. Lawrence, and E. Ben-Josef, “Inhibition of protein kinase Cβ by enzastaurin enhances radiation cytotoxicity in pancreatic cancer,” Clinical Cancer Research, vol. 13, no. 22, pp. 6827–6833, 2007. View at Publisher · View at Google Scholar · View at Scopus
  414. A. C. Spalding, B. D. Zeitlin, K. Wilder-Romans et al., “Enzastaurin, an inhibitor of PKCβ, enhances antiangiogenic effects and cytotoxicity of radiation against endothelial cells,” Translational Oncology, vol. 1, no. 4, pp. 195–201, 2008. View at Google Scholar
  415. D. Molè, T. Gagliano, E. Gentilin et al., “Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors,” Endocrine-Related Cancer, vol. 18, no. 4, pp. 439–450, 2011. View at Publisher · View at Google Scholar · View at Scopus
  416. L. V. Mauro, V. C. Grossoni, A. J. Urtreger et al., “PKC delta (PKCδ) promotes tumoral progression of human ductal pancreatic cancer,” Pancreas, vol. 39, no. 1, pp. e31–e41, 2010. View at Publisher · View at Google Scholar · View at Scopus
  417. B. Ozpolat, U. Akar, K. Mehta, and G. Lopei-Berestein, “PKCδ and tissue transglutaminase are novel inhibitors of autophagy in pancreatic cancer cells,” Autophagy, vol. 3, no. 5, pp. 480–483, 2007. View at Google Scholar · View at Scopus
  418. P. Cornford, J. Evans, A. Dodson et al., “Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer,” American Journal of Pathology, vol. 154, no. 1, pp. 137–144, 1999. View at Google Scholar · View at Scopus
  419. J. Villar, M. I. Arenas, C. M. MacCarthy, M. J. Blánquez, O. M. Tirado, and V. Notario, “PCPH/ENTPD5 expression enhances the invasiveness of human prostate cancer cells by a protein kinase Cδ-dependent mechanism,” Cancer Research, vol. 67, no. 22, pp. 10859–10868, 2007. View at Publisher · View at Google Scholar · View at Scopus
  420. C. Castilla, D. Chinchón, R. Medina, F. J. Torrubia, M. A. Japón, and C. Sáez, “PTPL1 and PKCδ contribute to proapoptotic signalling in prostate cancer cells,” Cell Death and Disease, vol. 4, article e576, 2013. View at Google Scholar
  421. R. Koren, D. Ben Meir, L. Langzam et al., “Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostate,” Oncology Reports, vol. 11, no. 2, pp. 321–326, 2004. View at Google Scholar · View at Scopus
  422. C. T. Powell, N. J. Brittis, D. Stec, H. Hug, W. D. W. Heston, and W. R. Fair, “Persistent membrane translocation of protein kinase C α during 12-O-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells,” Cell Growth & Differentiation, vol. 7, no. 4, pp. 419–428, 1996. View at Google Scholar · View at Scopus
  423. C. T. Powell and L. Yin, “Overexpression of PKCε sensitizes LNCaP human prostate cancer cells to induction of apoptosis by bryostatin 1,” International Journal of Cancer, vol. 118, no. 6, pp. 1572–1576, 2006. View at Publisher · View at Google Scholar · View at Scopus
  424. B. Liu, R. J. Maher, J. P. de Jonckheere et al., “12(S)-HETE increases the motility of prostate tumor cells through selective activation of PKC(α),” Advances in Experimental Medicine and Biology, vol. 400B, pp. 707–718, 1997. View at Google Scholar · View at Scopus
  425. M. L. G. Lamm, D. D. Long, S. M. Goodwin, and C. Lee, “Transforming growth factor-β1 inhibits membrane association of protein kinase Cα in a human prostate cancer cell line, PC3,” Endocrinology, vol. 138, no. 11, pp. 4657–4664, 1997. View at Publisher · View at Google Scholar · View at Scopus
  426. J. R. Stewart and C. A. O'Brian, “Protein kinase C-α mediates epidermal growth factor receptor transactivation in human prostate cancer cells,” Molecular Cancer Therapeutics, vol. 4, no. 5, pp. 726–732, 2005. View at Publisher · View at Google Scholar · View at Scopus
  427. O. M. Fischer, S. Hart, A. Gschwind, and A. Ullrich, “EGFR signal transactivation in cancer cells,” Biochemical Society Transactions, vol. 31, no. 6, pp. 1203–1208, 2003. View at Google Scholar · View at Scopus
  428. S. Jain, G. Chakraborty, and G. C. Kundu, “The crucial role of cyclooxygenase-2 in osteopontin-induced protein kinase C α/c-Src/IκB kinase α/β-dependent prostate tumor progression and angiogenesis,” Cancer Research, vol. 66, no. 13, pp. 6638–6648, 2006. View at Publisher · View at Google Scholar · View at Scopus
  429. J. Villar, H. S. Quadri, I. Song, Y. Tomita, O. M. Tirado, and V. Notario, “PCPH/ENTPD5 expression confers to prostate cancer cells resistance against cisplatin-induced apoptosis through protein kinase Cα-mediated Bcl-2 stabilization,” Cancer Research, vol. 69, no. 1, pp. 102–110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  430. A. Shih, S. Zhang, H. J. Cao et al., “Inhibitory effect of epidermal growth factor on resveratrol-induced apoptosis in prostate cancer cells is mediated by protien kinase C-α,” Molecular Cancer Therapeutics, vol. 3, no. 11, pp. 1355–1363, 2004. View at Google Scholar · View at Scopus
  431. J. Truman, S. A. Rotenberg, J. Kang et al., “PKCα activation downregulates ATM and radio-sensitizes androgen-sensitive human prostate cancer cells in vitro and in vivo,” Cancer Biology and Therapy, vol. 8, no. 1, pp. 54–63, 2009. View at Google Scholar · View at Scopus
  432. T. Kuo, W. Huang, and J. Guh, “WJ9708012 exerts anticancer activity through PKC-α related crosstalk of mitochondrial and endoplasmic reticulum stresses in human hormone-refractory prostate cancer cells,” Acta Pharmacologica Sinica, vol. 32, no. 1, pp. 89–98, 2011. View at Publisher · View at Google Scholar · View at Scopus
  433. J. E. Gschwend, W. R. Fair, and C. T. Powell, “Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase Cα,” Molecular Pharmacology, vol. 57, no. 6, pp. 1224–1234, 2000. View at Google Scholar · View at Scopus
  434. S. Rakoff-Nahoum and R. Medzhitov, “Toll-like receptors and cancer,” Nature Reviews Cancer, vol. 9, no. 1, pp. 57–63, 2009. View at Publisher · View at Google Scholar · View at Scopus
  435. L. A. Rindour, R. Y. Cheng, C. H. Switzer et al., “Molecular pathways: toll-like receptors in the tumor microenvironment-poor prognosis or new therapeutic opportunity,” Clinical Cancer Research, vol. 19, no. 6, pp. 1340–1346, 2013. View at Google Scholar
  436. A. Paone, D. Starace, R. Galli et al., “Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-α-dependent mechanism,” Carcinogenesis, vol. 29, no. 7, pp. 1334–1342, 2008. View at Publisher · View at Google Scholar · View at Scopus
  437. A. W. Tolcher, L. Reyno, P. M. Venner et al., “A randomized Phase II and pharmacokinetic study of the antisense oligonucleotides ISIS 3521 and ISIS 5132 in patients with hormone-refractory prostate cancer,” Clinical Cancer Research, vol. 8, no. 8, pp. 2530–2535, 2002. View at Google Scholar · View at Scopus
  438. B. B. Hafeez, W. Zhong, J. Weichert, N. E. Dreckschmidt, M. S. Jamal, and A. K. Verma, “Genetic ablation of PKC epsilon inhibits prostate cancer development and metastasis in transgenic mouse model of prostate adenocarcinoma,” Cancer Research, vol. 71, no. 6, pp. 2318–2327, 2011. View at Publisher · View at Google Scholar · View at Scopus
  439. J. Chen, F. Deng, S. V. Singh, and Q. J. Wang, “Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCε/PKD3 pathway downstream of Akt and ERK 1/2,” Cancer Research, vol. 68, no. 10, pp. 3844–3853, 2008. View at Publisher · View at Google Scholar · View at Scopus
  440. D. Wu, C. U. Thakore, G. G. Wescott, J. A. McCubrey, and D. M. Terrian, “Integrin signaling links protein kinase Cε to the protein kinase B/Akt survival pathway in recurrent prostate cancer cells,” Oncogene, vol. 23, no. 53, pp. 8659–8672, 2004. View at Publisher · View at Google Scholar · View at Scopus
  441. D. Wu, T. L. Foreman, C. W. Gregory et al., “Protein kinase Cε has the potential to advance the recurrence of human prostate cancer,” Cancer Research, vol. 62, no. 8, pp. 2423–2429, 2002. View at Google Scholar · View at Scopus
  442. D. Wu and D. M. Terrian, “Regulation of caveolin-1 expression and secretion by a protein kinase Cε signaling pathway in human prostate cancer cells,” The Journal of Biological Chemistry, vol. 277, no. 43, pp. 40449–40455, 2002. View at Publisher · View at Google Scholar · View at Scopus
  443. M. H. Aziz, H. T. Manoharan, D. R. Church et al., “Protein kinase Cε interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer,” Cancer Research, vol. 67, no. 18, pp. 8828–8838, 2007. View at Publisher · View at Google Scholar · View at Scopus
  444. J. Meshki, M. C. Caino, V. A. von Burstin, E. Griner, and M. G. Kazanietz, “Regulation of prostate cancer cell survival by protein kinase Cε involves bad phosphorylation and modulation of the TNFα/JNK pathway,” The Journal of Biological Chemistry, vol. 285, no. 34, pp. 26033–26040, 2010. View at Publisher · View at Google Scholar · View at Scopus
  445. R. Garg, J. Blando, C. J. Perez, H. B. Wang, F. J. Benavides, and M. G. Kazaniets, “Activation of nuclear factor κB (NF-κB) in prostate cancer is mediated by protein kinase C ϵ (PKCϵ),” The Journal of Biological Chemistry, vol. 287, no. 44, pp. 37570–37582, 2012. View at Google Scholar
  446. M. A. McJilton, C. van Sikes, G. G. Wescott et al., “Protein kinase Cε interacts with Bax and promotes survival of human prostate cancer cells,” Oncogene, vol. 22, no. 39, pp. 7958–7968, 2003. View at Publisher · View at Google Scholar · View at Scopus
  447. E. Flescher and R. Rotem, “Protein kinase C ε mediates the induction of P-glycoprotein in LNCaP prostate carcinoma cells,” Cellular Signalling, vol. 14, no. 1, pp. 37–43, 2002. View at Publisher · View at Google Scholar · View at Scopus
  448. S. Sarveswaran and J. Ghosh, “Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt,” International Journal of Oncology, vol. 41, no. 6, pp. 2191–2199, 2012. View at Google Scholar
  449. U. Gundimeda, J. E. Schiffman, D. Chhabra, J. Wong, A. Wu, and R. Gopalakrishna, “Locally generated methylseleninic acid induces specific inactivation of protein kinase C isoenzymes: relevance to selenium-induced apoptosis in prostate cancer cells,” The Journal of Biological Chemistry, vol. 283, no. 50, pp. 34519–34531, 2008. View at Publisher · View at Google Scholar · View at Scopus
  450. S. Sarveswaran, V. Thamilselvan, C. Brodie, and J. Ghosh, “Inhibition of 5-lipoxygenase triggers apoptosis in prostate cancer cells via down-regulation of protein kinase C-epsilon,” Biochimica et Biophysica Acta, vol. 1813, no. 12, pp. 2108–2117, 2011. View at Publisher · View at Google Scholar · View at Scopus
  451. B. B. Hafeez, W. Zhong, A. Mustafa, J. W. Fischer, O. Witkowsky, and A. K. Verma, “Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKCε, Stat3 and neuroendocrine markers,” Carcinogenesis, vol. 33, no. 12, pp. 2586–2592, 2012. View at Google Scholar
  452. J. Y. Kim, T. Valencia, S. Abu-Baker et al., “c-Myc phosphorylation by PKCζ represses prostate tumorigenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 16, pp. 6418–6423, 2013. View at Google Scholar
  453. A. M. Sánchez, S. Malagarie-Cazenave, N. Olea, D. Vara, C. Cuevas, and I. Díaz-Laviada, “Spisulosine (ES-285) induces prostate tumor PC-3 and LNCaP cell death by de novo synthesis of ceramide and PKCζ activation,” European Journal of Pharmacology, vol. 584, no. 2-3, pp. 237–245, 2008. View at Publisher · View at Google Scholar · View at Scopus
  454. S. Yao, A. Bee, D. Brewer et al., “Prkc-ζ expression promotes the aggressive phenotype of human prostate cancer cells and is a novel target for therapeutic intervention,” Genes & Cancer, vol. 1, no. 5, pp. 444–464, 2010. View at Publisher · View at Google Scholar · View at Scopus
  455. C. T. Powell, J. E. Gschwend, W. R. Fair, N. J. Brittis, D. Stec, and R. Huryk, “Overexpression of protein kinase C-zeta (PKC-ζ) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells,” Cancer Research, vol. 56, no. 18, pp. 4137–4141, 1996. View at Google Scholar · View at Scopus
  456. T. Inoue, T. Yoshida, Y. Shimizu et al., “Requirement of androgen-dependent activation of protein kinase Cζ for androgen-dependent cell proliferation in LNCaP cells and its roles in transition to androgen-independent cells,” Molecular Endocrinology, vol. 20, no. 12, pp. 3053–3069, 2006. View at Publisher · View at Google Scholar · View at Scopus
  457. J. Sonnemann, V. Gekeler, A. Sagrauske, C. Müller, H. Hofmann, and J. F. Beck, “Down-regulation of protein kinase Cη potentiates the cytotoxic effects of exogenous tumor necrosis factor-related apoptosis-inducing ligand in PC-3 prostate cancer cells,” Molecular Cancer Therapeutics, vol. 3, no. 7, pp. 773–781, 2004. View at Google Scholar · View at Scopus
  458. J. Kim, Y. Choi, A. Vallentin et al., “Centrosomal PKCβII and pericentrin are critical for human prostate cancer growth and angiogenesis,” Cancer Research, vol. 68, no. 16, pp. 6831–6839, 2008. View at Publisher · View at Google Scholar · View at Scopus
  459. P. Lu, C. Yu, P. Chiang et al., “Paclitaxel induces apoptosis through activation of nuclear protein kinase C-δ and subsequent activation of Golgi associated Cdk1 in human hormone refractory prostate cancer,” The Journal of Urology, vol. 186, no. 6, pp. 2434–2441, 2011. View at Publisher · View at Google Scholar · View at Scopus
  460. H. Wang, L. Xiao, and M. G. Kazanietz, “p23/Tmp21 associates with protein kinase Cδ (PKCδ) and modulates its apoptotic function,” The Journal of Biological Chemistry, vol. 286, no. 18, pp. 15821–15831, 2011. View at Publisher · View at Google Scholar · View at Scopus
  461. M. V. Gavrielides, A. M. Gonzalez-Guerrico, N. A. Riobo, and M. G. Kazanietz, “Androgens regulate protein kinase Cδ transcription and modulate its apoptotic function in prostate cancer cells,” Cancer Research, vol. 66, no. 24, pp. 11792–11801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  462. A. M. Gonzalez-Guerrico and M. G. Kazanietz, “Phorbol ester-induced apoptosis in prostate cancer cells via autocrine activation of the extrinsic apoptotic cascade: a key role for protein kinase Cδ,” The Journal of Biological Chemistry, vol. 280, no. 47, pp. 38982–38991, 2005. View at Publisher · View at Google Scholar · View at Scopus
  463. V. A. von Burstin, L. Xiao, and M. G. Kazanietz, “Bryostatin 1 inhibits phorbol ester-induced apoptosis in prostate cancer cells by differentially modulating protein kinase C (PKC) δ translocation and preventing PKCδ-mediated release of tumor necrosis factor-α,” Molecular Pharmacology, vol. 78, no. 3, pp. 325–332, 2010. View at Publisher · View at Google Scholar · View at Scopus
  464. L. Xiao, A. Gonzalez-Guerrico, and M. G. Kazanietz, “PKC-mediated secretion of death factors in LNCaP prostate cancer cells is regulated by androgens,” Molecular Carcinogenesis, vol. 48, no. 3, pp. 187–195, 2009. View at Publisher · View at Google Scholar · View at Scopus
  465. L. Xiao, M. Eto, and M. G. Kazanietz, “ROCK mediates phorbol ester-induced apoptosis in prostate cancer cells via p21Cip1 up-regulation and JNK,” The Journal of Biological Chemistry, vol. 284, no. 43, pp. 29365–29375, 2009. View at Publisher · View at Google Scholar · View at Scopus
  466. M. Sumitomo, R. Shen, J. S. Goldberg, J. Dai, D. Navarro, and D. M. Nanus, “Neutral endopeptidase promotes phorbol ester-induced apoptosis in prostate cancer cells by inhibiting neuropeptide-induced protein kinase C δ degradation,” Cancer Research, vol. 60, no. 23, pp. 6590–6596, 2000. View at Google Scholar · View at Scopus
  467. M. Sumitomo, M. Ohba, J. Asakuma et al., “Protein kinase Cδ amplifies ceramide formation via mitochondrial signaling in prostate cancer cells,” The Journal of Clinical Investigation, vol. 109, no. 6, pp. 827–836, 2002. View at Publisher · View at Google Scholar · View at Scopus
  468. S. Kharait, R. Dhir, D. Lauffenburger, and A. Wells, “Protein kinase Cδ signaling downstream of the EGF receptor mediates migration and invasiveness of prostate cancer cells,” Biochemical and Biophysical Research Communications, vol. 343, no. 3, pp. 848–856, 2006. View at Publisher · View at Google Scholar · View at Scopus
  469. H. S. Yu, T. H. Lin, and C. H. Tang, “Bradykinin enhances cell migration in human prostate cancer cells through B2 receptor/PKCδ/c-Src dependent signaling pathway,” Prostate, vol. 73, no. 1, pp. 89–100, 2013. View at Google Scholar
  470. J. Kim, T. Koyanagi, and D. Mochly-Rosen, “PKCIδ activation mediates angiogenesis via NADPH oxidase activity in PC-3 prostate cancer cells,” Prostate, vol. 71, no. 9, pp. 946–954, 2011. View at Publisher · View at Google Scholar · View at Scopus
  471. G. Kovacs, M. Akhtar, B. J. Beckwith et al., “The Heidelberg classification of renal cell tumours,” The Journal of Pathology, vol. 183, no. 2, pp. 131–133, 1997. View at Google Scholar · View at Scopus
  472. J. S. Lam, O. Shvarts, J. T. Leppert, R. A. Figlin, and A. S. Belldegrun, “Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy,” The Journal of Urology, vol. 173, no. 6, pp. 1853–1862, 2005. View at Publisher · View at Google Scholar · View at Scopus
  473. M. von Brandenstein, J. J. Pandarakalam, L. Kroon et al., “MicroRNA 15a, inversely correlated to PKCα, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples,” American Journal of Pathology, vol. 180, no. 5, pp. 1787–1797, 2012. View at Publisher · View at Google Scholar · View at Scopus
  474. W. Brenner, F. Benzing, J. Gudejko-Thiel et al., “Regulation of β1 integrin expression by PKCε in renal cancer cells,” International Journal of Oncology, vol. 25, no. 4, pp. 1157–1163, 2004. View at Google Scholar · View at Scopus
  475. R. Engers, S. Mrzyk, E. Springer et al., “Protein kinase C in human renal cell carcinomas: role in invasion and differential isoenzyme expression,” British Journal of Cancer, vol. 82, no. 5, pp. 1063–1069, 2000. View at Google Scholar · View at Scopus
  476. W. Brenner, G. Färber, T. Herget, C. Wiesner, J. G. Hengstler, and J. W. Thüroff, “Protein kinase C η is associated with progression of Renal Cell Carcinoma (RCC),” Anticancer Research, vol. 23, no. 5A, pp. 4001–4006, 2003. View at Google Scholar · View at Scopus
  477. Y. S. Pu, C. Y. Huang, J. Y. Chen et al., “Down-regulation of PKCζ in renal cell carcinoma and its clinicopathological implications,” Journal of Biomedical Science, vol. 19, article 39, 2012. View at Google Scholar
  478. K. Datta, J. Li, R. Bhattacharya, L. Gasparian, E. Wang, and D. Mukhopadhyay, “Protein kinase C ζ transactivates hypoxia-inducible factor α by promoting its association with p300 in renal cancer,” Cancer Research, vol. 64, no. 2, pp. 456–462, 2004. View at Publisher · View at Google Scholar · View at Scopus
  479. B. Huang, K. Cao, X. Li et al., “The expression and role of protein kinase C (PKC) epsilon in clear cell renal cell carcinoma,” Journal of Experimental and Clinical Cancer Research, vol. 30, no. 1, article 88, 2011. View at Publisher · View at Google Scholar · View at Scopus
  480. B. Zhan, C. Kong, K. Guo, and Z. Zhang, “PKCα is involved in the progression of kidney carcinoma through regulating netrin-1/UNC5B signaling pathway,” Tumor Biology, vol. 34, no. 3, pp. 1759–1766, 2013. View at Publisher · View at Google Scholar
  481. D. Lv, W. Zhao, D. Dong et al., “Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma,” European Journal of Cancer, vol. 47, no. 13, pp. 2068–2076, 2011. View at Publisher · View at Google Scholar · View at Scopus
  482. O. V. Razorenova, E. C. Finger, R. Colavitti et al., “VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKCδ-driven migration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 5, pp. 1931–1936, 2011. View at Publisher · View at Google Scholar · View at Scopus
  483. W. Brenner, I. Greber, J. Gudejko-Thiel et al., “Migration of renal carcinoma cells is dependent on protein kinase Cδ via β1 integrin and focal adhesion kinase,” International Journal of Oncology, vol. 32, no. 5, pp. 1125–1131, 2008. View at Google Scholar · View at Scopus
  484. K. Datta, R. Nambudripad, S. Pal, M. Zhou, H. T. Cohen, and D. Mukhopadhyay, “Inhibition of insulin-like growth factor-I-mediated cell signaling by the von Hippel-Lindau gene product in renal cancer,” The Journal of Biological Chemistry, vol. 275, no. 27, pp. 20700–20706, 2000. View at Publisher · View at Google Scholar · View at Scopus
  485. N. Bergelin, C. Löf, S. Balthasar, V. Kalhori, and K. Törnquist, “S1P1 and VEGFR-2 form a signaling complex with extracellularly regulated kinase 1/2 and protein kinase C-α regulating ML-1 thyroid carcinoma cell migration,” Endocrinology, vol. 151, no. 7, pp. 2994–3005, 2010. View at Publisher · View at Google Scholar · View at Scopus
  486. N. Bergelin, T. Blom, J. Heikkilä et al., “Sphingosine kinase as an oncogene: autocrine sphingosine 1-phoshate modulates ML-1 thyroid carcinoma cell migration by a mechanism dependent on protein kinase C-α and ERK1/2,” Endocrinology, vol. 150, no. 5, pp. 2055–2063, 2009. View at Publisher · View at Google Scholar · View at Scopus
  487. Y. Zhu, Q. Dong, B. J. Tan, W. G. Lim, S. Zhou, and W. Duan, “The PKCα-D294G mutant found in pituitary and thyroid tumors fails to transduce extracellular signals,” Cancer Research, vol. 65, no. 11, pp. 4520–4524, 2005. View at Publisher · View at Google Scholar · View at Scopus
  488. C. Prévostel, V. Alvaro, F. de Boisvilliers, A. Martin, C. Jaffiol, and D. Joubert, “The natural protein kinase Cα mutant is present in human thyroid neoplasms,” Oncogene, vol. 11, no. 4, pp. 669–674, 1995. View at Google Scholar · View at Scopus
  489. C. Prévostel, A. Martin, V. Alvaro, C. Jaffiol, and D. Joubert, “Protein kinase C alpha and tumorigenesis of the endocrine gland,” Hormone Research, vol. 47, no. 4–6, pp. 140–144, 1997. View at Google Scholar · View at Scopus
  490. A. Vallentin, T.-C. Lo, and D. Joubert, “A single point mutation in the V3 region affects protein kinase Cα targeting and accumulation at cell-cell contacts,” Molecular and Cellular Biology, vol. 21, no. 10, pp. 3351–3363, 2001. View at Publisher · View at Google Scholar · View at Scopus
  491. R. Assert, R. Kötter, U. Schiemann, P. Goretzki, and A. F. H. Pfeiffer, “Effects of the putatively oncogenic protein kinase Cα D294G mutation on enzymatic activity and cell growth and its occurrence in human thyroid neoplasias,” Hormone and Metabolic Research, vol. 34, no. 6, pp. 311–317, 2002. View at Publisher · View at Google Scholar · View at Scopus
  492. J. A. Knauf, L. S. Ward, Y. E. Nikiforov et al., “Isozyme-specific abnormalities of PKC in thyroid cancer: evidence for post-transcriptional changes in PKC epsilon,” The Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 5, pp. 2150–2159, 2002. View at Publisher · View at Google Scholar · View at Scopus
  493. X. Zhang, D. Li, M. Li et al., “MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development,” International Journal of Cancer, vol. 134, no. 2, pp. 257–267, 2014. View at Google Scholar
  494. J. A. Knauf, R. Elisei, D. Mochly-Rosen et al., “Involvement of protein kinase Cε (PKCε) in thyroid cell death. A truncated chimeric PKCε cloned from a thyroid cancer cell line protects thyroid cells from apoptosis,” The Journal of Biological Chemistry, vol. 274, no. 33, pp. 23414–23425, 1999. View at Publisher · View at Google Scholar · View at Scopus
  495. J. A. Knauf, B. Ouyang, M. Croyle, E. Kimura, and J. A. Fagin, “Acute expression of RET/PTC induces isozyme-specific activation and subsequent downregulation of PKCε in PCCL3 thyroid cells,” Oncogene, vol. 22, no. 44, pp. 6830–6838, 2003. View at Publisher · View at Google Scholar · View at Scopus
  496. D. Molè, E. Gentilin, T. Gagliano et al., “Protein kinase C: a putative new target for the control of human medullary thyroid carcinoma cell proliferation in vitro,” Endocrinology, vol. 153, no. 5, pp. 2088–2098, 2012. View at Publisher · View at Google Scholar · View at Scopus
  497. K. Koike, T. Fujii, A. M. Nakamura et al., “Activation of protein kinase C δ induces growth arrest in NPA thyroid cancer cells through extracellular signal-regulated kinase mitogen-activated protein kinase,” Thyroid, vol. 16, no. 4, pp. 333–341, 2006. View at Publisher · View at Google Scholar · View at Scopus
  498. E. Afrasiabi, J. Ahlgren, N. Bergelin, and K. Törnquist, “Phorbol 12-myristate 13-acetate inhibits FRO anaplastic human thyroid cancer cell proliferation by inducing cell cycle arrest in G1/S phase: evidence for an effect mediated by PKCδ,” Molecular and Cellular Endocrinology, vol. 292, no. 1-2, pp. 26–35, 2008. View at Publisher · View at Google Scholar · View at Scopus
  499. N. Li, Z. X. Du, Z. H. Zong et al., “PKCδ-mediated phosphorylation of BAG3 at Ser187 site induces epithelial-mesenchymal transition and enhances invasiveness in thyroid cancer FRO cells,” Oncogene, vol. 32, no. 88, pp. 4539–4548, 2013. View at Google Scholar
  500. L. Zhang, J. Huang, N. Yang et al., “Integrative genomic analysis of protein kinase C (PKC) family identifies PKCι as a biomarker and potential oncogene in ovarian carcinoma,” Cancer Research, vol. 66, no. 9, pp. 4627–4635, 2006. View at Publisher · View at Google Scholar · View at Scopus
  501. J. H.. Kang, T. Mori, H. Kitazaki et al., “Kinase activity of protein kinase cα in serum as a diagnostic biomarker of human lung cancer,” Anticancer Research, vol. 33, no. 2, pp. 485–488, 2013. View at Google Scholar
  502. J. H.. Kang, T. Mori, H. Kitazaki et al., “Serum protein kinase Cα as a diagnostic biomarker of cancers,” Cancer Biomarkers, vol. 13, no. 2, pp. 99–103, 2013. View at Google Scholar
  503. L. A. Davidson, C. M. Aymond, Y. Jiang, N. D. Turner, J. R. Lupton, and R. S. Chapkin, “Non-invasive detection of fecal protein kinase C βII and ζ messenger RNA: putative biomarkers for colon cancer,” Carcinogenesis, vol. 19, no. 2, pp. 253–257, 1998. View at Publisher · View at Google Scholar · View at Scopus
  504. L. A. Davidson, Y. Jiang, J. R. Lupton, and R. S. Chapkin, “Noninvasive detection of putative biomarkers for colon cancer using fecal messenger RNA,” Cancer Epidemiology Biomarkers & Prevention, vol. 4, no. 6, pp. 643–647, 1995. View at Google Scholar · View at Scopus
  505. Q. Pan, L. W. Bao, C. G. Kleer et al., “Protein kinase Cε is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy,” Cancer Research, vol. 65, no. 18, pp. 8366–8371, 2005. View at Publisher · View at Google Scholar · View at Scopus
  506. C. Cordon-Cardo, J. P. O'Brien, J. Boccia, D. Casals, J. R. Bertino, and M. R. Melamed, “Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues,” Journal of Histochemistry and Cytochemistry, vol. 38, no. 9, pp. 1277–1287, 1990. View at Google Scholar · View at Scopus
  507. I. Sugawara, S. Akiyama, R. J. Scheper, and S. Itoyama, “Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRP,” Cancer Letters, vol. 112, no. 1, pp. 23–31, 1997. View at Publisher · View at Google Scholar · View at Scopus
  508. D. S. Cox, K. R. Scott, H. Gao, and N. D. Eddington, “Effect of P-glycoprotein on the pharmacokinetics and tissue distribution of enaminone anticonvulsants: analysis by population and physiological approaches,” Journal of Pharmacology and Experimental Therapeutics, vol. 302, no. 3, pp. 1096–1104, 2002. View at Publisher · View at Google Scholar · View at Scopus
  509. C. Sauvant, M. Nowak, C. Wirth et al., “Acidosis induces multi-drug resistance in rat prostate cancer cells (AT1) in vitro and in vivo by increasing the activity of the p-glycoprotein via activation of p38,” International Journal of Cancer, vol. 123, no. 11, pp. 2532–2542, 2008. View at Publisher · View at Google Scholar · View at Scopus
  510. C. R. Carmo, J. Lyons-Lewis, M. J. Seckl, and A. P. Costa-Pereira, “A novel requirement for Janus Kinases as mediators of drug resistance induced by fibroblast growth factor-2 in human cancer cells,” PLoS ONE, vol. 6, no. 5, Article ID e19861, 2011. View at Publisher · View at Google Scholar · View at Scopus
  511. S. Daenen, B. van der Holt, G. E. G. Verhoef et al., “Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adults,” Leukemia Research, vol. 28, no. 10, pp. 1057–1067, 2004. View at Publisher · View at Google Scholar · View at Scopus
  512. M. R. Baer, S. L. George, R. K. Dodge et al., “Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: cancer and Leukemia Group B study 9720,” Blood, vol. 100, no. 4, pp. 1224–1232, 2002. View at Google Scholar · View at Scopus
  513. M. Hu, Y. Liu, C. Deng et al., “Enhanced invasiveness in multidrug resistant leukemic cells is associated with overexpression of P-glycoprotein and cellular inhibitor of apoptosis protein,” Leukemia & Lymphoma, vol. 52, no. 7, pp. 1302–1311, 2011. View at Publisher · View at Google Scholar · View at Scopus
  514. T. Reya, S. J. Morrison, M. F. Clarke, and I. L. Weissman, “Stem cells, cancer, and cancer stem cells,” Nature, vol. 414, no. 6859, pp. 105–111, 2001. View at Publisher · View at Google Scholar · View at Scopus
  515. L. V. Nguyen, R. Vanner, P. Dirks, and C. J. Eaves, “Cancer stem cells: an evolving concept,” Nature Reviews Cancer, vol. 12, no. 2, pp. 133–143, 2012. View at Publisher · View at Google Scholar · View at Scopus
  516. L. Y. W. Bourguignon, C. Earle, G. Wong, C. C. Spevak, and K. Krueger, “Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells,” Oncogene, vol. 31, no. 2, pp. 149–160, 2012. View at Publisher · View at Google Scholar · View at Scopus
  517. L. Y. W. Bourguignon, K. Peyrollier, W. Xia, and E. Gilad, “Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells,” The Journal of Biological Chemistry, vol. 283, no. 25, pp. 17635–17651, 2008. View at Publisher · View at Google Scholar · View at Scopus
  518. L. Y. W. Bourguignon, G. Wong, C. Earle, and L. Chen, “Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma,” The Journal of Biological Chemistry, vol. 287, no. 39, pp. 32800–32824, 2012. View at Google Scholar
  519. W. K. Chu, P. M. Dai, H. L. Ki, C. C. Pao, and J. K. Chen, “Nanog expression is negatively regulated by protein kinase C activities in human cancer cell lines,” Oncogene, vol. 34, no. 7, pp. 1497–1509, 2013. View at Google Scholar
  520. A. Singh, A. Singh, J. M. Sand, E. Heninger, B. B. Hafeez, and A. K. Verma, “Protein kinase Cε, which is linked to ultraviolet radiation-induced development of squamous cell carcinomas, stimulates rapid turnover of adult hair follicle stem cells,” Journal of Skin Cancer, vol. 2013, Article ID 452425, 13 pages, 2013. View at Publisher · View at Google Scholar
  521. H. Harrison, G. Farnie, S. J. Howell et al., “Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor,” Cancer Research, vol. 70, no. 2, pp. 709–718, 2010. View at Publisher · View at Google Scholar · View at Scopus
  522. J. Yun, A. Pannuti, I. Espinoza et al., “Crosstalk between PKCα and Notch-4 in endocrine-resistant breast cancer cells,” Oncogenesis, vol. 2, article e60, 2013. View at Google Scholar
  523. W. L. Tam, H. Lu, J. Buikhuisen et al., “Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells,” Cancer Cell, vol. 24, no. 3, pp. 347–364, 2013. View at Google Scholar
  524. B. L. J. Webb, S. J. Hirst, and M. A. Giembycz, “Protein kinase C isoenzymes: a review of their structure, regulation and role in regulating airways smooth muscle tone and mitogenesis,” British Journal of Pharmacology, vol. 130, no. 7, pp. 1433–1452, 2000. View at Google Scholar · View at Scopus